SearchStrings |
1 | 1314 | 20.96 | &esrc=s |
2 | 742 | 11.84 | tropical journal of pharmaceutical resea... |
3 | 164 | 2.62 | tjpr |
4 | 104 | 1.66 | solid dispersion |
5 | 98 | 1.56 | &source=web |
6 | 42 | 0.67 | images of orodispersible |
7 | 33 | 0.53 | nanotechnology in drug delivery |
8 | 30 | 0.48 | (Google Cache) |
9 | 30 | 0.48 | coating withhpmc 6 cps |
10 | 29 | 0.46 | chitosan as an anti-oxidant activity (pd... |
11 | 29 | 0.46 | orally disintegrating tablets |
12 | 29 | 0.46 | floating microspheres |
13 | 28 | 0.45 | gelucire 50/13 xray diffraction |
14 | 28 | 0.45 | tropical journal of pharmaceutical resea... |
15 | 22 | 0.35 | optimal crosslinking ratio filetype:pdf |
16 | 21 | 0.33 | tropical journal of pharmaceutical resea... |
17 | 20 | 0.32 | antilaishmania |
18 | 19 | 0.30 | microencapsulation microcapsule or polym... |
19 | 16 | 0.26 | manoi 2007 sirih merah |
20 | 16 | 0.26 | nanotechnology in drug delivery pdf |
21 | 16 | 0.26 | nigella sativa chromatography phytochem ... |
22 | 15 | 0.24 | orally disintegrating tablet |
23 | 15 | 0.24 | trop j pharm res |
24 | 14 | 0.22 | review article in curcumin loaded in dru... |
25 | 14 | 0.22 | oral disintegrating tablet |
26 | 14 | 0.22 | anticonvulsant activity |
27 | 12 | 0.19 | determination of serum glutamate pyruvat... |
28 | 12 | 0.19 | rapidly disintegrating tablets pdf |
29 | 12 | 0.19 | p53 and p21 liver cirrhosis |
30 | 12 | 0.19 | formulation and evaluation of carbamaze... |
31 | 12 | 0.19 | drug delivery in nanotechnology |
32 | 12 | 0.19 | nanotechnology drug delivery |
33 | 12 | 0.19 | glibencamide nanoparticles surfactant |
34 | 12 | 0.19 | fast releasing gel formulations |
35 | 11 | 0.18 | piroxicam transdermal patches formulatio... |
36 | 11 | 0.18 | oral disintegrating tablets |
37 | 11 | 0.18 | orally disintegrated tablet |
38 | 10 | 0.16 | fast dissolving tablet an overview |
39 | 10 | 0.16 | determination of serum glutamate transam... |
40 | 10 | 0.16 | determination of serum slutamate oxalate... |
41 | 10 | 0.16 | curcumin floating |
42 | 9 | 0.14 | piper crocatum |
43 | 9 | 0.14 | penetration enhancers transdermal |
44 | 9 | 0.14 | kai yang sitophilus zeamais paederia |
45 | 9 | 0.14 | separation of metronidazole |
46 | 9 | 0.14 | http://www.tjpr.org/ |
47 | 9 | 0.14 | knowledge attitude and practice of diarr... |
48 | 9 | 0.14 | tropical journal of pharmaceutical scien... |
49 | 9 | 0.14 | journal piper crosatum |
50 | 9 | 0.14 | bioequivalence study of metronidazole su... |
51 | 8 | 0.13 | chemical penetration enhancers for trans... |
52 | 8 | 0.13 | effect of suppository bases on physical ... |
53 | 8 | 0.13 | rapidly disintegrating tablets |
54 | 8 | 0.13 | 14 |
55 | 8 | 0.13 | orodispersible tablet review |
56 | 8 | 0.13 | celecoxib sustained release |
57 | 8 | 0.13 | "p aminoacetophenone" filetype:pdf |
58 | 8 | 0.13 | nanotechnology in pharmaceuticals |
59 | 8 | 0.13 | huang yt et al.(2007) formulated the sus... |
60 | 8 | 0.13 | antiepileptic activity by pentylene tetr... |
61 | 7 | 0.11 | http://www.tjpr.org/vol11_no5/2012_11_5_... |
62 | 7 | 0.11 | drug delivery: like a virus.pdf |
63 | 7 | 0.11 | tropican journal of pharmacy reserach |
64 | 7 | 0.11 | application of nanotechnology in drug de... |
65 | 7 | 0.11 | tropical journal |
66 | 7 | 0.11 | tropical j of pharmaceutical research |
67 | 7 | 0.11 | stability indicating analytical methods |
68 | 6 | 0.10 | www.tjpr.org |
69 | 6 | 0.10 | stability indicating method |
70 | 6 | 0.10 | complement c4 serum high |
71 | 6 | 0.10 | related:tpjk-cyilquj:scholar.google.com/ |
72 | 6 | 0.10 | merve eylul bozkurt |
73 | 6 | 0.10 | what are od tablet medicine |
74 | 6 | 0.10 | ethnobotany: a methods manual |
75 | 6 | 0.10 | oral dissolving tablets |
76 | 6 | 0.10 | tropical journal of pharmaceutical resea... |
77 | 6 | 0.10 | eudragit microsphere |
78 | 6 | 0.10 | orodispersible tablet |
79 | 6 | 0.10 | tropical journal of pharmacy research |
80 | 6 | 0.10 | orally disintegrating tablets |
81 | 6 | 0.10 | metronidazole biopharmaceutical |
82 | 6 | 0.10 | orally disintegrating tablets, drug deli... |
83 | 6 | 0.10 | 2 |
84 | 6 | 0.10 | oral disintegrating technologies |
85 | 6 | 0.10 | journal of microbial metabolism filetype... |
86 | 6 | 0.10 | trop j. pharm. res |
87 | 6 | 0.10 | challenges in formulating odts: |
88 | 6 | 0.10 | orodispersible tablets research articals |
89 | 6 | 0.10 | odt tablets |
90 | 6 | 0.10 | gastroretentive filetype:pdf |
91 | 6 | 0.10 | automated coating machine by a p gadad ... |
92 | 6 | 0.10 | erim gulcan |
93 | 6 | 0.10 | barriers to penetration through transde... |
94 | 6 | 0.10 | disintegration time of sublingual tablet... |
95 | 5 | 0.08 | comparison of disintegration profiles |
96 | 5 | 0.08 | nanotechnology and drug delivery |
97 | 5 | 0.08 | fast dissolving tablet review |
98 | 5 | 0.08 | knowledge about diabetes |
99 | 5 | 0.08 | nanotechnology drug delivery pdf |
100 | 5 | 0.08 | anticonvulsant activity pdf |
101 | 5 | 0.08 | oral disintegrating tablets review |
102 | 5 | 0.08 | pdf osmotic drug delivery using swellabl... |
103 | 5 | 0.08 | ethyl cellulose filetype:pdf |
104 | 5 | 0.08 | eudragit floating microspheres |
105 | 5 | 0.08 | nanotechnology- applications in drug del... |
106 | 5 | 0.08 | nanotechnology in drug |
107 | 5 | 0.08 | nanotechnology in drug delivery system |
108 | 5 | 0.08 | fast dissolving tablets review |
109 | 5 | 0.08 | oral disintegrating tablet.pdf |
110 | 5 | 0.08 | (effect of nature of suppository base us... |
111 | 5 | 0.08 | concentration and ranges of hydroxy prop... |
112 | 5 | 0.08 | hair growth promoting activity, herbs |
113 | 5 | 0.08 | effect of nature of suppository base use... |
114 | 5 | 0.08 | research articles on orodispersible tabl... |
115 | 5 | 0.08 | review articles on orodispersible tablet... |
116 | 5 | 0.08 | orodispersible tablets |
117 | 4 | 0.06 | epidemiology of snake bites in nigeria, ... |
118 | 4 | 0.06 | cobalt (ii) complex "1 nitroso 2 naphtho... |
119 | 4 | 0.06 | nanotechnology in disease treatment:pdf |
120 | 4 | 0.06 | topican journal of pharmacy research |
121 | 4 | 0.06 | selection of drugs for the orodispersibl... |
122 | 4 | 0.06 | artocarpin cancer filetype:pdf |
123 | 4 | 0.06 | effects of plants on decrease in sod, ca... |
124 | 4 | 0.06 | phénolic compound of juniperus filetype... |
125 | 4 | 0.06 | inhibition of inos and dna oxidation by ... |
126 | 4 | 0.06 | journal of chemical and pharmaceutical r... |
127 | 4 | 0.06 | penetration enhancer |
128 | 4 | 0.06 | reham microbiology gamal fadl |
129 | 4 | 0.06 | side effect artemisinin filetype:pdf |
130 | 4 | 0.06 | disadvantage of orally disintegrating ta... |
131 | 4 | 0.06 | tjpr.org |
132 | 4 | 0.06 | ticagrelor hplc method |
133 | 4 | 0.06 | evaluation of odt |
134 | 4 | 0.06 | antiepileptic activity.pdf |
135 | 4 | 0.06 | tjpr journal |
136 | 4 | 0.06 | rehana parveen cedrus deodara |
137 | 4 | 0.06 | drug delivery and nanotechnology |
138 | 4 | 0.06 | anti-inflammatory and antipyretic activi... |
139 | 4 | 0.06 | orally disintegrating tabler |
140 | 4 | 0.06 | piper crocatum pdf |
141 | 4 | 0.06 | tropical j pharmaceutical research |
142 | 4 | 0.06 | knowledge on diabetes mellitus in self c... |
143 | 4 | 0.06 | jashanjit singh and rajmeet singh. ... |
144 | 4 | 0.06 | analytical standart metronidazole |
145 | 4 | 0.06 | jacob rajaonarivelo |
146 | 4 | 0.06 | limonia acidissima |
147 | 4 | 0.06 | tropical journal pharmaceutical research |
148 | 4 | 0.06 | formulation meloxicam for oral pdf |
149 | 4 | 0.06 | copper sulfate enzyme inhibitor |
150 | 4 | 0.06 | penetration enhancer compatible with cep... |
151 | 4 | 0.06 | pharmainfo.net.dissolution.2008 |
152 | 4 | 0.06 | comparison of disintegration profiles . |
153 | 4 | 0.06 | tropical journal of pharmaceutical rese... |
154 | 4 | 0.06 | download ethnobotany: a methods manual |
155 | 4 | 0.06 | artemether and lumefantrine tablets form... |
156 | 4 | 0.06 | tropical journal of pharmaceutical r... |
157 | 4 | 0.06 | role of biotechnology in plants |
158 | 4 | 0.06 | dead space wound model |
159 | 4 | 0.06 | 3 |
160 | 4 | 0.06 | when first discovered nanotechnology ? ... |
161 | 4 | 0.06 | research article in microspheres of glip... |
162 | 4 | 0.06 | tablet disintegrate time in git |
163 | 4 | 0.06 | amino acid antioxidant and ionic profil... |
164 | 4 | 0.06 | review article on oral disintegrating ta... |
165 | 4 | 0.06 | . rahman a, ‘development and in vitro ... |
166 | 4 | 0.06 | ratio of solvent used in film |
167 | 4 | 0.06 | orally disintegrating tablets a review |
168 | 4 | 0.06 | mutagonda et al. |
169 | 4 | 0.06 | journal of pharmaceutical research 2012;... |
170 | 4 | 0.06 | impact of nanotechnology in drug develop... |
171 | 4 | 0.06 | review paper on nanotechnology |
172 | 4 | 0.06 | comparison of disintegration profiles co... |
173 | 4 | 0.06 | pharmaceutical preparations in the marke... |
174 | 4 | 0.06 | hygrophila spinosa |
175 | 4 | 0.06 | journal drugs with nanotechnology pdf |
176 | 4 | 0.06 | investigation of in vitro release kineti... |
177 | 4 | 0.06 | permeation enhancer for the transderman ... |
178 | 4 | 0.06 | hplc tropical |
179 | 4 | 0.06 | how to type a manuscript |
180 | 4 | 0.06 | benefits that are obtained from pharmace... |
181 | 4 | 0.06 | chitosan as an antioxidant (pdf) |
182 | 4 | 0.06 | tropical journal of pharmaceutical resea... |
183 | 4 | 0.06 | pregnancy associated brucellosis. |
184 | 4 | 0.06 | nonotechnology for drug delivery |
185 | 4 | 0.06 | future trends of nanotechnology in drug ... |
186 | 3 | 0.05 | parts of ulcer das |
187 | 3 | 0.05 | nanotechnology procedure for drug discov... |
188 | 3 | 0.05 | nanotechnology applications in pharmaceu... |
189 | 3 | 0.05 | nanotechnology drug delivery system |
190 | 3 | 0.05 | synthetic of cosmetics/pdf |
191 | 3 | 0.05 | assessment of knowledge on diabetes mell... |
192 | 3 | 0.05 | biodegradable injectable in situ forming... |
193 | 3 | 0.05 | tablet formulation for grdds |
194 | 3 | 0.05 | oral disintegration tablet |
195 | 3 | 0.05 | download nonatechnology in drug delivery |
196 | 3 | 0.05 | journal with impact factor ethnobotany |
197 | 3 | 0.05 | piper crocatum ruiz & pav |
198 | 3 | 0.05 | nanotechnology in pharmaceutics |
199 | 3 | 0.05 | odt tablets disadvantaous |
200 | 3 | 0.05 | nelson a ochekpe, patrick o olorunfemi a... |
201 | 3 | 0.05 | celecoxib microspheres pdf |
202 | 3 | 0.05 | filetype:pdf key determination of violac... |
203 | 3 | 0.05 | diabetic ketoacidosis |
204 | 3 | 0.05 | research of diuretic filetype:pdf |
205 | 3 | 0.05 | drug for preperation of odt |
206 | 3 | 0.05 | tjpr impact factor |
207 | 3 | 0.05 | fast disintegrating tablets review |
208 | 3 | 0.05 | selection of drugs for the orodispersibl... |
209 | 3 | 0.05 | molecular weight of hpmc k4m |
210 | 3 | 0.05 | editor@tjpr.org |
211 | 3 | 0.05 | reviews of oral cavity tablets |
212 | 3 | 0.05 | mechanism.enhancer.gliserin.pdf |
213 | 3 | 0.05 | transdermal enhancer |
214 | 3 | 0.05 | synthesis of nanoparticles by solvent ev... |
215 | 3 | 0.05 | discriminatory features of dosage form a... |
216 | 3 | 0.05 | comparison of disintegration profiles. |
217 | 3 | 0.05 | oral disintegration tablet bdf |
218 | 3 | 0.05 | nanotechnology for drug delivery |
219 | 3 | 0.05 | knowledge deficit about diabetes |
220 | 3 | 0.05 | trop j pharm res, |
221 | 3 | 0.05 | kap on use of oral rehydration therapy a... |
222 | 3 | 0.05 | isolation of terpenoid compound.pdf |
223 | 3 | 0.05 | tlc solvent system using pet ether, acet... |
224 | 3 | 0.05 | ethnobotany |
225 | 3 | 0.05 | dmso skin penetration |
226 | 3 | 0.05 | site:tjpr.org tropical journal of pharm... |
227 | 3 | 0.05 | eudragit polymers follow which drug rele... |
228 | 3 | 0.05 | c3 and c4 in sle |
229 | 3 | 0.05 | filetype:pdf advantages and disadvantage... |
230 | 3 | 0.05 | k. p. bhusari pdf |
231 | 3 | 0.05 | discriminatory features of dosage form a... |
232 | 3 | 0.05 | management losartan potassium filetype:p... |
233 | 3 | 0.05 | tropican journal of pharmacy resrach |
234 | 3 | 0.05 | nanotechnology materials drug delivery |
235 | 3 | 0.05 | disintegration specification of odt tabl... |
236 | 2 | 0.03 | nanotechnology in pharmaceutical manufac... |
237 | 2 | 0.03 | formulation of tablets reviews filetype... |
238 | 2 | 0.03 | chronotherapeutic drug delivery systems ... |
239 | 2 | 0.03 | 2θ value of gelucire 50/13 |
240 | 2 | 0.03 | professor ojewole |
241 | 2 | 0.03 | methanol protein precipitation |
242 | 2 | 0.03 | how to improve the disintegration of the... |
243 | 2 | 0.03 | medicinal uses of artocarpus altilis |
244 | 2 | 0.03 | oral disintegrating tablets how work |
245 | 2 | 0.03 | nanotechnological delivery of drugs |
246 | 2 | 0.03 | antipyretic activity research article of... |
247 | 2 | 0.03 | pharmacists traditional role dispensing |
248 | 2 | 0.03 | professor obianwu |
249 | 2 | 0.03 | tropical journal of pharmaceutical resea... |
250 | 2 | 0.03 | dicyclomine hydrochloride microsonge art... |
251 | 2 | 0.03 | who with patient waiting time |
252 | 2 | 0.03 | tropical journal of |
253 | 2 | 0.03 | pharmaceutical drug manufacturing proces... |
254 | 2 | 0.03 | nutmeg fruit fall*physiological disorder |
255 | 2 | 0.03 | comparative costs of antibacterial usage... |
256 | 2 | 0.03 | nanotechnology in pharmacy pdf |
257 | 2 | 0.03 | lihuiying email |
258 | 2 | 0.03 | sukun pdf |
259 | 2 | 0.03 | studies on medicinal plants in treatment... |
260 | 2 | 0.03 | online education + saudi arabia + univ... |
261 | 2 | 0.03 | levofloxacin for cap filetype:pdf 2010..... |
262 | 2 | 0.03 | various drugs used in floating microsphe... |
263 | 2 | 0.03 | patient's diabetes knowledge questionnai... |
264 | 2 | 0.03 | imapacr factor oftropical pharmaceutical... |
265 | 2 | 0.03 | recent advancement in tablet and capsule... |
266 | 2 | 0.03 | penetration enhancer for topical use |
267 | 2 | 0.03 | bupropion hydrochloride tablets |
268 | 2 | 0.03 | journal of tropical pharmaceutical resea... |
269 | 2 | 0.03 | “sustained release diltiazem matrix ta... |
270 | 2 | 0.03 | tropical journal of pharmaceutical resea... |
271 | 2 | 0.03 | punch test using ta xt plus texture anal... |
272 | 2 | 0.03 | literature review of orally disintegrati... |
273 | 2 | 0.03 | behzad sharif makhmal zade + armita |
274 | 2 | 0.03 | baboota |
275 | 2 | 0.03 | caffeen and staph aureus,antimicrobial |
276 | 2 | 0.03 | analytical method of tenofovir disoproxi... |
277 | 2 | 0.03 | sida acuta alkaloids |
278 | 2 | 0.03 | hypoglycemic activity test using sucrose... |
279 | 2 | 0.03 | effect of hypolidemic herbal extract on ... |
280 | 2 | 0.03 | disintegrating tablet |
281 | 2 | 0.03 | orally disintegrating tablets. deepak k |
282 | 2 | 0.03 | mytracarpus scaber |
283 | 2 | 0.03 | chronotherapy new advances filetype:pdf |
284 | 2 | 0.03 | calculation of tablet formulation |
285 | 2 | 0.03 | hair growth promotant activity of petrol... |
286 | 2 | 0.03 | ancient history of nanotechnology |
287 | 2 | 0.03 | ganesh chaulang, ashok bhosale, piyush p... |
288 | 2 | 0.03 | drugs in nanotechnology |
289 | 2 | 0.03 | tropican journal of pharmacy rerserach |
290 | 2 | 0.03 | skin penetration enhancer |
291 | 2 | 0.03 | paracetamol+antipyretic+in rat |
292 | 2 | 0.03 | cholest,5,25-diene,diol |
293 | 2 | 0.03 | tropical journal of pharmacy |
294 | 2 | 0.03 | phytochemical screening |
295 | 2 | 0.03 | pharmaceutical +91 @yahoo.com |
296 | 2 | 0.03 | journal of water treatment for injection... |
297 | 2 | 0.03 | pharmacological activities of plumeria.r... |
298 | 2 | 0.03 | microsponges |
299 | 2 | 0.03 | journal antioxidant oryza sativa |
300 | 2 | 0.03 | effect of cream formulation of fenugreek... |
301 | 2 | 0.03 | c3 nephritis |
302 | 2 | 0.03 | pharmacist and primary health care pdf |
303 | 2 | 0.03 | www,tjpre org/ |
304 | 2 | 0.03 | sitagliptin stability indicating method ... |
305 | 2 | 0.03 | role of nanotechnology in the discovery ... |
306 | 2 | 0.03 | physical tablet properties of effervesce... |
307 | 2 | 0.03 | phytochemical screening of medicinal pla... |
308 | 2 | 0.03 | formets for process validation in pharma |
309 | 2 | 0.03 | review pharmaceutical nanotechnology fil... |
310 | 2 | 0.03 | rakesh pahwa, mona piplani, prabodh c sh... |
311 | 2 | 0.03 | tropical journal of pharmaceutical resea... |
312 | 2 | 0.03 | carvedilol sustained release tablet form... |
313 | 2 | 0.03 | amino acid solution production technique... |
314 | 2 | 0.03 | tropical journal of phamacology resrsrch |
315 | 2 | 0.03 | solid dispersion |
316 | 2 | 0.03 | lepidium sativum filetype:pdf |
317 | 2 | 0.03 | how to make nutraceutical tablets pdf |
318 | 2 | 0.03 | controlled release carvedilol matrix tab... |
319 | 2 | 0.03 | research papers on hydroxyl radical scav... |
320 | 2 | 0.03 | odt tablet |
321 | 2 | 0.03 | capric acid as penetration enhancer for... |
322 | 2 | 0.03 | what are applications of ethnobotany in ... |
323 | 2 | 0.03 | how to make toothpaste pdf |
324 | 2 | 0.03 | filetype:pdf optimization techniques in ... |
325 | 2 | 0.03 | drugs global issue |
326 | 2 | 0.03 | compound isolated from bridelia ferrugin... |
327 | 2 | 0.03 | tropical journal of westindies |
328 | 2 | 0.03 | c3 and c4 serum |
329 | 2 | 0.03 | swelling of mcc |
330 | 2 | 0.03 | nothapodytes it antimicrobial activity k... |
331 | 2 | 0.03 | screening of anticonvulsant activity |
332 | 2 | 0.03 | phenyl group antibacterial |
333 | 2 | 0.03 | eudragit rspo coating |
334 | 2 | 0.03 | are pharmacists rich in nigeria |
335 | 2 | 0.03 | a review on fast disintegrating tablets |
336 | 2 | 0.03 | osmotic pump tablet pdf |
337 | 2 | 0.03 | optimization and development of swellabl... |
338 | 2 | 0.03 | journal drugs of carbamazepine.pdf |
339 | 2 | 0.03 | pharma research |
340 | 2 | 0.03 | orally disintegrating tablets: a review |
341 | 2 | 0.03 | a study to assess the knowledge regardin... |
342 | 2 | 0.03 | tropican journal of pharmacy |
343 | 2 | 0.03 | synergy between phenothiazines and oxaci... |
344 | 2 | 0.03 | procedure for sustained release matrix ... |
345 | 2 | 0.03 | orodispersible tablet of |
346 | 2 | 0.03 | mn-al tablets manufacturing process |
347 | 2 | 0.03 | cefuroxime axetil crystalline |
348 | 2 | 0.03 | phytochemical costituents of adiantum lu... |
349 | 2 | 0.03 | dip coating of eudragit l100 |
350 | 2 | 0.03 | antipyrtic activity |
351 | 2 | 0.03 | tropical journal of pharmaceutical j |
352 | 2 | 0.03 | pharmaceutical validation |
353 | 2 | 0.03 | filetype:pdf periodontitis treatment sit... |
354 | 2 | 0.03 | determination of metronidazole in human ... |
355 | 2 | 0.03 | arq badian |
356 | 2 | 0.03 | providing pharmacuetical care services t... |
357 | 2 | 0.03 | orodispersible tablet.pdf |
358 | 2 | 0.03 | application of nanotechology in pharmacy... |
359 | 2 | 0.03 | jurnal carica papaya filetype:pdf |
360 | 2 | 0.03 | us pharmacopeia donepezil orodispersible |
361 | 2 | 0.03 | trop j pharm res. 2009, 8(2):133-137 |
362 | 2 | 0.03 | nanotechnology medicine pdf lecture |
363 | 2 | 0.03 | myth and reality of computer |
364 | 2 | 0.03 | microsponges preparation |
365 | 2 | 0.03 | increased complement c4 serum |
366 | 2 | 0.03 | application ofmettalic( copper) nanowire... |
367 | 2 | 0.03 | tropican jouranl of pharmacy resrach |
368 | 2 | 0.03 | tropical journal of pharmaceutical resea... |
369 | 2 | 0.03 | hpmc 5cps is low viscosity or high visco... |
370 | 2 | 0.03 | drug delivery histor |
371 | 2 | 0.03 | drudg delivery for nanotechnology |
372 | 2 | 0.03 | challenge drug delivery filetype:pdf |
373 | 2 | 0.03 | abbas azadmehr |
374 | 2 | 0.03 | which chemical permeation enhancers poss... |
375 | 2 | 0.03 | preparation method for sustain release m... |
376 | 2 | 0.03 | kim sung-jin + kyung hee university |
377 | 2 | 0.03 | home management of diarrhoea |
378 | 2 | 0.03 | dissolution profile for artesunate and a... |
379 | 2 | 0.03 | antivonvulsion activity |
380 | 2 | 0.03 | journal abstract on use of phyllanthus c... |
381 | 2 | 0.03 | cinnamomum zeylanicum n. |
382 | 2 | 0.03 | chitosan-pectin+capsul filetype:pdf |
383 | 2 | 0.03 | rosmarinic acid+isicratic hplc |
384 | 2 | 0.03 | review of literature on tablets |
385 | 2 | 0.03 | njamen d |
386 | 2 | 0.03 | carissa carandas |
387 | 2 | 0.03 | 10.4314/tjpr.v11i5.14 |
388 | 2 | 0.03 | tablet drug review of literature |
389 | 2 | 0.03 | role of emergency room pharmacist |
390 | 2 | 0.03 | glyceryl palmitostearate tablets |
391 | 2 | 0.03 | gene expression effected by herbal treat... |
392 | 2 | 0.03 | 15965996 |
393 | 2 | 0.03 | formulation and evaluation of fast disso... |
394 | 2 | 0.03 | antimicrobial susceptibility of communit... |
395 | 2 | 0.03 | review article of fast disintigrating ta... |
396 | 2 | 0.03 | research article tropical and infection ... |
397 | 2 | 0.03 | orally disintegrating film new approach |
398 | 2 | 0.03 | example disintegrating agent pdf |
399 | 2 | 0.03 | formulation and evaluation of oral disi... |
400 | 2 | 0.03 | protein delivery, nanotechnology |
401 | 2 | 0.03 | patient care vs pharmaceutical care |
402 | 2 | 0.03 | nanotechnology and drug delivery part 2 |
403 | 2 | 0.03 | ethnobotany medicinal values |
404 | 2 | 0.03 | method of ethnobotany |
405 | 2 | 0.03 | difference between lansoprazole orodispe... |
406 | 2 | 0.03 | concentration of mannitol in tablet |
407 | 2 | 0.03 | review articles sustained release matrix... |
408 | 2 | 0.03 | metformin uv ethanol pdf |
409 | 2 | 0.03 | formulation and evaluation of floating m... |
410 | 2 | 0.03 | filetype:pdf managing diarrhea at home |
411 | 2 | 0.03 | tropical journal of pharmaceutical resea... |
412 | 2 | 0.03 | how does propylene glycol work as a perm... |
413 | 2 | 0.03 | mucoadhesive bioadhesive systems oral ... |
414 | 2 | 0.03 | research articles on paremidical staff |
415 | 2 | 0.03 | malaysia dka |
416 | 2 | 0.03 | antiparasitic natural hydroxyl structure... |
417 | 2 | 0.03 | south african journal of pharmaceutical ... |
418 | 2 | 0.03 | factors affecting adherence among diabet... |
419 | 2 | 0.03 | desert date in oral cancer |
420 | 2 | 0.03 | differencs between oral disintegrating a... |
421 | 2 | 0.03 | tropical journal of pharmaceutical resea... |
422 | 2 | 0.03 | nadeem(2003) patient waiting and satisfa... |
423 | 2 | 0.03 | chitneni mallikarjun |
424 | 2 | 0.03 | nano technology and drug delivery |
425 | 2 | 0.03 | journal anticonvulsant.pdf |
426 | 2 | 0.03 | artocarpus altilis, mda |
427 | 2 | 0.03 | application of nanotechnology in drug de... |
428 | 2 | 0.03 | tropican journal of pharamcy reserach |
429 | 2 | 0.03 | paracetamol- biuret test |
430 | 2 | 0.03 | orally dissolving tablets |
431 | 2 | 0.03 | controlled release matrix tablet hpmc tr... |
432 | 2 | 0.03 | biochemical marker of myocardial infarct... |
433 | 2 | 0.03 | medical nanotechnology pdf |
434 | 2 | 0.03 | instruction to author international j of... |
435 | 2 | 0.03 | why are polar and nonpolar interactions ... |
436 | 2 | 0.03 | effect of polymers on spherical agglomer... |
437 | 2 | 0.03 | dr pradeep vavia article list |
438 | 2 | 0.03 | diol betulin?query=diol betulin |
439 | 2 | 0.03 | toothpaste pdf |
440 | 2 | 0.03 | pdf drug release |
441 | 2 | 0.03 | http://www.tjpr.org/vol11_no5/2012_11_5_... |
442 | 2 | 0.03 | chitosan fresh keeping pdf filetype:pdf |
443 | 2 | 0.03 | the directory of open access journals (... |
444 | 2 | 0.03 | tropical journal of |
445 | 2 | 0.03 | eudragit l100 and eudragit l 100 contain... |
446 | 2 | 0.03 | determination of plasma pdf |
447 | 2 | 0.03 | fast disintegrating tablt review article... |
448 | 2 | 0.03 | drugs which can be used for orally disin... |
449 | 2 | 0.03 | disintegrating |
450 | 2 | 0.03 | chemical enhancers for sc delivery |
451 | 2 | 0.03 | anti-inflammatory and antipyretic activi... |
452 | 2 | 0.03 | normal c3 and c4 levels |
453 | 2 | 0.03 | mitrowska k, posyniak a, zmudzki j. mult... |
454 | 2 | 0.03 | anticancer - indian herbs - g2m arrest |
455 | 2 | 0.03 | paraquat intoxication protocol |
456 | 2 | 0.03 | journal of pharmaceutical research 2012;... |
457 | 2 | 0.03 | torpical journal of pharmaceutical resea... |
458 | 2 | 0.03 | patra et al. (2008). |
459 | 2 | 0.03 | interaction of sodium starch glycolate w... |
460 | 2 | 0.03 | coating by drug solution |
461 | 2 | 0.03 | bkdas72@northsouth.edu |
462 | 2 | 0.03 | assay of metformin by uv |
463 | 2 | 0.03 | pharmaceutical process validation |
464 | 2 | 0.03 | orally disintegrating sustain release ta... |
465 | 2 | 0.03 | how to detect loq and lod in hplc |
466 | 2 | 0.03 | penetration enhancers in transdermal sys... |
467 | 2 | 0.03 | nanotechnology+its applications in drug ... |
468 | 2 | 0.03 | amorph solid dispersion |
469 | 2 | 0.03 | journal of herbal medicine of indonesia,... |
470 | 2 | 0.03 | fluconazole+essential oil=antibacterial |
471 | 2 | 0.03 | gloriosa superba research in india |
472 | 2 | 0.03 | permeation enhancers pdf |
473 | 2 | 0.03 | p.daisy pdf |
474 | 2 | 0.03 | thin layer chromatography for surfectant... |
475 | 2 | 0.03 | recent advanced approaches in formulatio... |
476 | 2 | 0.03 | journal of ethyl cellulose polymer used ... |
477 | 2 | 0.03 | pharma smoth film coating.com |
478 | 2 | 0.03 | effectsofcassiaoccidentalis |
479 | 2 | 0.03 | essential oil from balanites aegyptiaca ... |
480 | 2 | 0.03 | erÄm gÜlcan |
481 | 2 | 0.03 | cefuroxime bcs system |
482 | 2 | 0.03 | bio adhesive filetype:pdf |
483 | 2 | 0.03 | anticonvulsant.pdf |
484 | 2 | 0.03 | " hanen falleh " mail |
485 | 2 | 0.03 | tropical journal of pharmaceutical r... |
486 | 2 | 0.03 | 10.4314/tjpr.v11i5.14 |
487 | 2 | 0.03 | microsphere and gel in periodontal pocke... |
488 | 2 | 0.03 | journal of pharmacy research + doi |
489 | 2 | 0.03 | a literature review on nanomedicine drug... |
490 | 2 | 0.03 | zakiullah pharmacy peshawar university |
491 | 2 | 0.03 | gc and gc-ms essential oil+pdf |
492 | 2 | 0.03 | bohevia diffisa |
493 | 2 | 0.03 | yelly oktavia sari |
494 | 2 | 0.03 | sustained release matrix tablets of dilt... |
495 | 2 | 0.03 | bupropion hydrochloride tablets formulat... |
496 | 2 | 0.03 | brewers yeast flavonoids |
497 | 2 | 0.03 | tropican njournal of pharmacy reserach |
498 | 2 | 0.03 | evaluation of ointment filetype:pdf |
499 | 2 | 0.03 | research articles on osmotic pump tablet |
500 | 2 | 0.03 | quercus infectoria toxicity |
501 | 2 | 0.03 | nanotechnology in drug delivery |
502 | 2 | 0.03 | nanotechnoiogy recent approaches in pha... |
503 | 2 | 0.03 | index medicus list of pharmacy journals |
504 | 2 | 0.03 | université de cocody, departement de bi... |
505 | 2 | 0.03 | patient satisfaction pharmacy |
506 | 2 | 0.03 | dissolution specifications for sustained... |
507 | 2 | 0.03 | quantitative ethnobotany research method... |
508 | 2 | 0.03 | inayat bashir pathan citation |
509 | 2 | 0.03 | copper sulphate enzyme inhibitor |
510 | 2 | 0.03 | antioxidant activity of the bulb and aer... |
511 | 2 | 0.03 | suppress cough strips |
512 | 2 | 0.03 | history of drug delivery |
513 | 2 | 0.03 | antipyretic activity of |
514 | 2 | 0.03 | uv method for metronidazole |
515 | 2 | 0.03 | ritah mutagonda |
516 | 2 | 0.03 | penetration of medicines under skin |
517 | 2 | 0.03 | simvastatin tablet monograph as per usp ... |
518 | 2 | 0.03 | sesame oil ppar |
519 | 2 | 0.03 | pharmaceutical |
520 | 2 | 0.03 | nanostructure drug delivery vehicle |
521 | 2 | 0.03 | modeling biological activities of nanopa... |
522 | 2 | 0.03 | 6 |
523 | 2 | 0.03 | tropical journal of pharmaceutical resea... |
524 | 2 | 0.03 | myristica fragrans extract and flavanoid... |
525 | 2 | 0.03 | ir edta acivity |
526 | 2 | 0.03 | characteristics of odt |
527 | 2 | 0.03 | challenges in formulation of odts |
528 | 2 | 0.03 | stability indicating method hplc |
529 | 2 | 0.03 | http:\\www.tjpr.freehosting.net |
530 | 2 | 0.03 | disintegration time too fast |
531 | 2 | 0.03 | phtochemical study of nut meg |
532 | 2 | 0.03 | benefits odt tablets |
533 | 2 | 0.03 | patient waiting time |
534 | 2 | 0.03 | journal of pharmaceutical research |
535 | 2 | 0.03 | comparison of disintegration profiles co... |
536 | 2 | 0.03 | 1 |
537 | 2 | 0.03 | patient satisfaction of pharmacy practic... |
538 | 2 | 0.03 | odt tablet formulations |
539 | 2 | 0.03 | ingredient of zydis odt |
540 | 2 | 0.03 | drug delivery system in nanotechnology |
541 | 2 | 0.03 | factors influencing desintegration of or... |
542 | 2 | 0.03 | drug delivery book, pdf |
543 | 2 | 0.03 | abstract of glorissa superba |
544 | 2 | 0.03 | providing pharmaceutical care services t... |
545 | 2 | 0.03 | journal application of nanotechnology to... |
546 | 2 | 0.03 | skin layers penetrated before delivering... |
547 | 2 | 0.03 | review article on oral disintegrating ta... |
548 | 2 | 0.03 | osmotic pumps articles |
549 | 2 | 0.03 | kalanchoe secies in cameroon |
550 | 2 | 0.03 | filetype:pdf immunostimulatory test of n... |
551 | 2 | 0.03 | "self-assembly"+protein+ribosome+biotech... |
552 | 2 | 0.03 | protocol for in vitro phagocytosis assay... |
553 | 2 | 0.03 | filetype:pdf peg ratio site:org |
554 | 2 | 0.03 | donepazil odt tablets bioequivalence st... |
555 | 2 | 0.03 | allintitle: salvia -divinorum -splendens... |
556 | 2 | 0.03 | transmucsal routs of drug delivery offe... |
557 | 2 | 0.03 | tramadol hydrochloride matrix tablets |
558 | 2 | 0.03 | physicians awareness on roles of clinica... |
559 | 2 | 0.03 | intermittent preventive therapy and trea... |
560 | 2 | 0.03 | "disintegration time" odt |
561 | 2 | 0.03 | wikipedia advantages of nano technology |
562 | 2 | 0.03 | tropic journal of pharmaceutical researc... |
563 | 2 | 0.03 | price of poloxamer 407 in nigeria |
564 | 2 | 0.03 | polyopes |
565 | 2 | 0.03 | metformin uv pdf |
566 | 2 | 0.03 | phytochemistry of saraca asoca |
567 | 2 | 0.03 | name of tablet of ashoka stem |
568 | 2 | 0.03 | how to reduce waiting time in the pharma... |
569 | 2 | 0.03 | microsphere preparation by solvent evapo... |
570 | 2 | 0.03 | dicyclomine research articles |
571 | 2 | 0.03 | tropical journal of pharmaceutical rese... |
572 | 2 | 0.03 | nephroprotective k v s r g prasad |
573 | 2 | 0.03 | method development artemether and lumefa... |
574 | 2 | 0.03 | penetration enhancer mechanism |
575 | 2 | 0.03 | gloriosa superba abstract |
576 | 2 | 0.03 | pumpkin seed oil pdf |
577 | 2 | 0.03 | newbouldia laevis |
578 | 2 | 0.03 | journal of tropical pharmaceutical scien... |
579 | 2 | 0.03 | a theoretical basis for a biopharmaceuti... |
580 | 2 | 0.03 | transdermal filetype:pdf |
581 | 2 | 0.03 | nanotechnology drugs |
582 | 2 | 0.03 | stability indicating hplc method for bu... |
583 | 2 | 0.03 | javed ali in pharmacy jamia hamdard |
584 | 2 | 0.03 | revies on oral disintegrating |
585 | 2 | 0.03 | nanotechnology.pdf |
586 | 2 | 0.03 | lobeline pharmaceutical preparations in ... |
587 | 2 | 0.03 | disintegration odt tablets in usp |
588 | 2 | 0.03 | anti inflammatory activity plumeria rubr... |
589 | 2 | 0.03 | use of starch 1500 lm as a diluent in e... |
590 | 2 | 0.03 | research articles on gloriosa superba |
591 | 2 | 0.03 | periodontal filetype:pdf |
592 | 2 | 0.03 | indomethacin containing microspheres pdf |
593 | 2 | 0.03 | metformin ethanol uv pdf |
594 | 2 | 0.03 | a review article of oral disintegrating ... |
595 | 2 | 0.03 | treatment of bruceloses during pregnancy |
596 | 2 | 0.03 | phamaceutical agency drugs and productio... |
597 | 2 | 0.03 | effect of coating solution preparation o... |
598 | 2 | 0.03 | artemisinin-based combination therapy (a... |
599 | 2 | 0.03 | rapidly dissolving tablets pdf download |
600 | 2 | 0.03 | how does water getting into tablets help... |
601 | 2 | 0.03 | diabetic ketoacidosis malaysia |
602 | 2 | 0.03 | bitter kola and kidney |
603 | 2 | 0.03 | model of anticonvolucent activity |
604 | 2 | 0.03 | composition of maxim insecticide |
605 | 2 | 0.03 | probodh c sharma publications |
606 | 2 | 0.03 | medicinal plants with anticonvulsant act... |
607 | 2 | 0.03 | lupus and c3 and c4 levels |
608 | 2 | 0.03 | ethnobotany index |
609 | 2 | 0.03 | amoxicillin caffeine |
610 | 2 | 0.03 | c3 and c4 serum complement |
611 | 2 | 0.03 | standard curve of curcumin in 0.1 n hcl |
612 | 2 | 0.03 | sethi journal pharmaceutical research |
613 | 2 | 0.03 | are dissolvable psych meds as effective ... |
614 | 2 | 0.03 | http://tjpr.org/ |
615 | 2 | 0.03 | co-artesiane |
616 | 2 | 0.03 | xenorhabdus pdf |
617 | 2 | 0.03 | tamer baykara |
618 | 2 | 0.03 | journal article adverse drug reactions f... |
619 | 2 | 0.03 | su kun po medical research" |
620 | 2 | 0.03 | compatibility of dicyclomine with eudrgi... |
621 | 2 | 0.03 | topical steroid creams and penetration e... |
622 | 2 | 0.03 | osmotic pump tablets without laser drill... |
623 | 2 | 0.03 | http://www.tjpr.org |
624 | 2 | 0.03 | gc mass method of calculating sterols co... |
625 | 2 | 0.03 | s. madan, g .n. singh, k. kohli, m. ali,... |
626 | 2 | 0.03 | oral disintegrating tablet formulation |
627 | 2 | 0.03 | journal of pharmaceutical research 2012 ... |
628 | 2 | 0.03 | international journal chitosan alginate ... |
629 | 2 | 0.03 | diabetes in nigeria |
630 | 2 | 0.03 | sustain release solid dispersion pdf |
631 | 2 | 0.03 | aspergillus fumigatus soap |
632 | 2 | 0.03 | advances in formulation of orally disint... |
633 | 2 | 0.03 | absorption enhancer pdf |
634 | 2 | 0.03 | tropican journal of pharamcy research |
635 | 2 | 0.03 | problems of using chemical enhancers in ... |
636 | 2 | 0.03 | pharmacologic therapy of hypertension fi... |
637 | 2 | 0.03 | journal of pharmaceutical tanzania |
638 | 2 | 0.03 | eudragit rs/rl polymers sustained releas... |
639 | 2 | 0.03 | sukun pdf |
640 | 2 | 0.03 | dina shabranskaya yulia |
641 | 2 | 0.03 | carissa carandas biological activity |
642 | 2 | 0.03 | patient monitor nigeria |
643 | 2 | 0.03 | fast disintegrating dosage form platform... |
644 | 2 | 0.03 | challenges in development of malaria vac... |
645 | 2 | 0.03 | types of solvent effects |
646 | 2 | 0.03 | "shahid iqbal" |
647 | 2 | 0.03 | how the saltform of the drug gets disint... |
648 | 2 | 0.03 | rspo rlpo eudragit review |
649 | 2 | 0.03 | metformin tablet in form of gastroreten... |
650 | 2 | 0.03 | impact of nanotechnology on drug deliver... |
651 | 2 | 0.03 | solubility of cefuroxime axetil in hcl |
652 | 2 | 0.03 | transmucosal route of drug |
653 | 2 | 0.03 | management of diabetic ketoacidosis in m... |
654 | 2 | 0.03 | hardness range of orally disintegrating ... |
655 | 2 | 0.03 | diclofenac loaded microspheres pdf |
656 | 2 | 0.03 | urea as enhancer mechanism |
657 | 2 | 0.03 | mechanism of ethonol as penetration in t... |
658 | 2 | 0.03 | chemicals that penetrate the skin |
659 | 2 | 0.03 | can you cut an orally disintegrating tab... |
660 | 2 | 0.03 | nanotechnology in drugs |
661 | 2 | 0.03 | computer aided design of experiment for ... |
662 | 2 | 0.03 | articles on the chronotherapeutic drug ... |
663 | 2 | 0.03 | meloxicam (method of analysis) |
664 | 2 | 0.03 | infra red spectra of taraxerone |
665 | 2 | 0.03 | donepezil hydrochloride fast dissolving ... |
666 | 2 | 0.03 | dk50 diabetes |
667 | 2 | 0.03 | transdermal drug delivery system pdf |
668 | 2 | 0.03 | polymers for floating drug delivery syst... |
669 | 2 | 0.03 | crowded plate technique |
670 | 2 | 0.03 | terminalia bellerica+pdf |
671 | 2 | 0.03 | ddsolver |
672 | 1 | 0.02 | • jaysukh j hirani et al, “orally di... |
673 | 1 | 0.02 | what is ethnobotany why is it important |
674 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
675 | 1 | 0.02 | what is drug delivery |
676 | 1 | 0.02 | fullerene as drug delivery filetype:pdf |
677 | 1 | 0.02 | antiulcer activity + mangifera indica + ... |
678 | 1 | 0.02 | medicinal value of golden seal plants in... |
679 | 1 | 0.02 | microbiology department in university of... |
680 | 1 | 0.02 | hydroxypropyl methylcellulose coated tab... |
681 | 1 | 0.02 | ethylcellulose microsphere |
682 | 1 | 0.02 | pharma process validation pdf |
683 | 1 | 0.02 | sirichet rattanachitthawat |
684 | 1 | 0.02 | assay of amodiaquine from united state ... |
685 | 1 | 0.02 | pore former for controlled porosity osmo... |
686 | 1 | 0.02 | pharmacy practice in the 60s |
687 | 1 | 0.02 | to conclude, shorter disintegration time... |
688 | 1 | 0.02 | nanotechnology drugs examples |
689 | 1 | 0.02 | azone penetration enhancer |
690 | 1 | 0.02 | abuja 2001@yahoo.com |
691 | 1 | 0.02 | current research on lilliaceae pdf |
692 | 1 | 0.02 | mucoadhesive drug delivery system review... |
693 | 1 | 0.02 | optimization of serratiopeptidase |
694 | 1 | 0.02 | journal manager what do they do |
695 | 1 | 0.02 | faheem daghestani |
696 | 1 | 0.02 | milling for sublingual tablets |
697 | 1 | 0.02 | molar solution of ceftriaxone |
698 | 1 | 0.02 | what disintegrates faster |
699 | 1 | 0.02 | values of accuracy,precision,lod,loq |
700 | 1 | 0.02 | s a sreenivas |
701 | 1 | 0.02 | pyman shalchian |
702 | 1 | 0.02 | site:tjpr.org tropical journal of pharma... |
703 | 1 | 0.02 | can b complex increase urea |
704 | 1 | 0.02 | eudragit rspo and rlpo film |
705 | 1 | 0.02 | biological and pharmaceutical nanomateri... |
706 | 1 | 0.02 | tropical journal of phermaceuticals if |
707 | 1 | 0.02 | • formulation and optimization of cele... |
708 | 1 | 0.02 | saraca indica in delhi |
709 | 1 | 0.02 | review of fast disintegrating tablet |
710 | 1 | 0.02 | solvent displacement method for the prep... |
711 | 1 | 0.02 | introduction of orodispersible tablet sy... |
712 | 1 | 0.02 | copper drug delivery |
713 | 1 | 0.02 | clausena suffruticosa |
714 | 1 | 0.02 | commercial stability |
715 | 1 | 0.02 | low complement c3 c4 |
716 | 1 | 0.02 | formulations of orally disintegrating ta... |
717 | 1 | 0.02 | &usg=afqjcnek4qasrmus4psqnh7oyhxpgllr8g |
718 | 1 | 0.02 | acacia pods antifungal filetype:pdf |
719 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
720 | 1 | 0.02 | tropical pharmaceutical research journal |
721 | 1 | 0.02 | www;ufr ssmt org |
722 | 1 | 0.02 | green tea health filetype:pdf |
723 | 1 | 0.02 | glycyrrhiza glabra for hair care pdf |
724 | 1 | 0.02 | disintegration time pdf |
725 | 1 | 0.02 | ethnobotany information |
726 | 1 | 0.02 | pharmaceutical care filetype:pdf |
727 | 1 | 0.02 | research papers related with how drugs p... |
728 | 1 | 0.02 | rosmarinic acid determination hplc+isocr... |
729 | 1 | 0.02 | general film coating formula hydroalcol... |
730 | 1 | 0.02 | celecoxib, cellulose acetate buytrate, s... |
731 | 1 | 0.02 | download of nanotechnology papers presen... |
732 | 1 | 0.02 | international journal of pharmaceutical ... |
733 | 1 | 0.02 | stability indicating method pdf |
734 | 1 | 0.02 | технология orally disintegrati... |
735 | 1 | 0.02 | tropicn journal of pharmacy research |
736 | 1 | 0.02 | c4 serum test high in child |
737 | 1 | 0.02 | disadvantages of disintegrating tablets |
738 | 1 | 0.02 | ビュッヒ el130 |
739 | 1 | 0.02 | application of nanotechnology in drug de... |
740 | 1 | 0.02 | which of the following dosage forms bypa... |
741 | 1 | 0.02 | tropical journal of pharmacical research |
742 | 1 | 0.02 | onset fast disintegrating tablet vs regu... |
743 | 1 | 0.02 | silica nanotube imprinted for drug deliv... |
744 | 1 | 0.02 | professor friday okonofua + email |
745 | 1 | 0.02 | trop.j.pharm. res |
746 | 1 | 0.02 | waiting time in hospitals analyses |
747 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
748 | 1 | 0.02 | metronidazole bioequivalence study time ... |
749 | 1 | 0.02 | dna-drug interaction pdf 2012 |
750 | 1 | 0.02 | diethylnitrosamine hepg2 |
751 | 1 | 0.02 | drugs and nanotechnology |
752 | 1 | 0.02 | meloxicam wet granulation |
753 | 1 | 0.02 | donepezil sublingual |
754 | 1 | 0.02 | difference between sublingual tablet and... |
755 | 1 | 0.02 | antioxidant effect of chitosan |
756 | 1 | 0.02 | journal of ethyl cellulose polymer used ... |
757 | 1 | 0.02 | expidet versus tablets |
758 | 1 | 0.02 | nanotechnology definition drugs |
759 | 1 | 0.02 | bioequivalence of metronidazole and ezze... |
760 | 1 | 0.02 | tropican journal of pharmacy reserch] |
761 | 1 | 0.02 | what is the zone of inhibition using tet... |
762 | 1 | 0.02 | potential causes to long pharmacy wait t... |
763 | 1 | 0.02 | spontaneous emulsification solvent diffu... |
764 | 1 | 0.02 | challenges of irradiated sporozoite vacc... |
765 | 1 | 0.02 | bottled water,bpa |
766 | 1 | 0.02 | biotechnology production of antibiotics ... |
767 | 1 | 0.02 | impact factor tropical journal pharmaceu... |
768 | 1 | 0.02 | penetration enhancer + pdf |
769 | 1 | 0.02 | differences between dulcolax and sennosi... |
770 | 1 | 0.02 | viscosity hpmc 5cps |
771 | 1 | 0.02 | • determination of drug –polymer com... |
772 | 1 | 0.02 | groups in losartan potassium+ftir |
773 | 1 | 0.02 | formulation evaluation of floating micro... |
774 | 1 | 0.02 | filetype:doc comments on prospectus |
775 | 1 | 0.02 | nanotechnology application drug delivery |
776 | 1 | 0.02 | mucoadhesive tablet using solid dispersi... |
777 | 1 | 0.02 | tropical journal of pharmacy reserach |
778 | 1 | 0.02 | obitte nicholas |
779 | 1 | 0.02 | odt tablet formulation |
780 | 1 | 0.02 | formulation and evaluation of ampicillin... |
781 | 1 | 0.02 | e journal manager |
782 | 1 | 0.02 | how to determine kinetic analysis of dru... |
783 | 1 | 0.02 | - tropical journal of pharmaceutical res... |
784 | 1 | 0.02 | serum complement c3 |
785 | 1 | 0.02 | test on sensitivity to antibiotics is e... |
786 | 1 | 0.02 | diabetes knowledge levels in pharmacists |
787 | 1 | 0.02 | dissolution of oral disintegrating table... |
788 | 1 | 0.02 | application of nanotechnology in plant d... |
789 | 1 | 0.02 | assessment of pharmacist knowledge |
790 | 1 | 0.02 | why hydro alcohols are generally used so... |
791 | 1 | 0.02 | pin wall in nanotechnology nem and nem |
792 | 1 | 0.02 | "smell" of methanol extract mangifera in... |
793 | 1 | 0.02 | low c3 and normal c4 decreased igg |
794 | 1 | 0.02 | filetype:pdf nerium oleander |
795 | 1 | 0.02 | meloxicam stability |
796 | 1 | 0.02 | hplc method on tramadol hydrochloride |
797 | 1 | 0.02 | oral disintegrating tablets pdf |
798 | 1 | 0.02 | oral thin film manufacturing machinery |
799 | 1 | 0.02 | knowledge deficit in diabetes |
800 | 1 | 0.02 | formualtion calculation of tablet accord... |
801 | 1 | 0.02 | dicyclomine y preparation h |
802 | 1 | 0.02 | cabatbat am. the effect of health educat... |
803 | 1 | 0.02 | metoprolol succinate buccal film |
804 | 1 | 0.02 | lecture drug delivery: controlled rele... |
805 | 1 | 0.02 | historical background nanotechnology |
806 | 1 | 0.02 | orange book, an fdt as “a solid dosage... |
807 | 1 | 0.02 | olmesartan in sublingual form project |
808 | 1 | 0.02 | peer review process in pharmaceutical st... |
809 | 1 | 0.02 | sample volume dissolution testing |
810 | 1 | 0.02 | reversal of liver fibrosis in chronic mu... |
811 | 1 | 0.02 | research articles of oral drug disintigr... |
812 | 1 | 0.02 | nano in drug delivery |
813 | 1 | 0.02 | natural antioxidant for papaya filetype:... |
814 | 1 | 0.02 | can orally disintegrating tablets be cut... |
815 | 1 | 0.02 | drug dvery applications using nanotechno... |
816 | 1 | 0.02 | hypogltcemic effect of bridelia ferrugin... |
817 | 1 | 0.02 | impact of research on topical plants in ... |
818 | 1 | 0.02 | brilinta hplc method |
819 | 1 | 0.02 | disintegration and bioavailability |
820 | 1 | 0.02 | diarrhea qatar incidence children |
821 | 1 | 0.02 | elevated complement c4 serum |
822 | 1 | 0.02 | emergency department pharmacy services i... |
823 | 1 | 0.02 | phytochemical test with alakloid |
824 | 1 | 0.02 | orally disintegrating tablets pdf |
825 | 1 | 0.02 | oral wafer protein drug delivery |
826 | 1 | 0.02 | evaluation test for oral disintigrating ... |
827 | 1 | 0.02 | elevated complement c4 serum level |
828 | 1 | 0.02 | hair growth enhancer pdf |
829 | 1 | 0.02 | "daucus carota " topical filetype:pdf |
830 | 1 | 0.02 | sustained release peg 400 pdf |
831 | 1 | 0.02 | antimicrobial activity of methanolic ext... |
832 | 1 | 0.02 | analysis of out patient waiting time |
833 | 1 | 0.02 | cefadroxil lambda max |
834 | 1 | 0.02 | disintegrating tablets literatures |
835 | 1 | 0.02 | oral dispersion tablets |
836 | 1 | 0.02 | microsponge drug delivery system higuchi |
837 | 1 | 0.02 | how many doses of ipt does a pregnant wo... |
838 | 1 | 0.02 | standardization of nigella sativa.pdf |
839 | 1 | 0.02 | prescribing pattern of antihypertensives... |
840 | 1 | 0.02 | difference between oral disintegrating ... |
841 | 1 | 0.02 | hirani orally disintegrating tablet |
842 | 1 | 0.02 | shaibu + gentamicin |
843 | 1 | 0.02 | polyethylene oxide)– polypropylene oxi... |
844 | 1 | 0.02 | pdf jurnal of leaf exctract amarantus tr... |
845 | 1 | 0.02 | tolfenamic acid as a drug delivery agent |
846 | 1 | 0.02 | the effectiveness of antimicrobial agent... |
847 | 1 | 0.02 | stephen o okp, department of pharmacolo... |
848 | 1 | 0.02 | syed m nurulain |
849 | 1 | 0.02 | stability indicating methods for hplc |
850 | 1 | 0.02 | paederia scandens filetype:pdf |
851 | 1 | 0.02 | odt indan pharmacopeias |
852 | 1 | 0.02 | parameter for antioxidant activity filet... |
853 | 1 | 0.02 | sgrs college of pharmacy saswad dsc |
854 | 1 | 0.02 | formulation of antioxidant gel carbopol.... |
855 | 1 | 0.02 | drug delivery definition |
856 | 1 | 0.02 | diuresis and sodium filetype:pdf |
857 | 1 | 0.02 | multiparticulate drug dilevery system |
858 | 1 | 0.02 | dr.deepak bhagwat in pharma journals |
859 | 1 | 0.02 | tropical journal of pharmaceutical |
860 | 1 | 0.02 | release of drug from alginate filetype:p... |
861 | 1 | 0.02 | solid dispersion ftir |
862 | 1 | 0.02 | mechanism of water-soluble drug release ... |
863 | 1 | 0.02 | odt tablets production |
864 | 1 | 0.02 | hplc method devlopment of maloxicam and ... |
865 | 1 | 0.02 | herbal tablet.pdf |
866 | 1 | 0.02 | formulation and evaluation of stavudine ... |
867 | 1 | 0.02 | nanotechnology in medicine in new invent... |
868 | 1 | 0.02 | superporous hydrogel as drug delivery sy... |
869 | 1 | 0.02 | a review of medicinal plants showing ant... |
870 | 1 | 0.02 | tropical journal of pharmaceutical rese... |
871 | 1 | 0.02 | tropical journal of pharm |
872 | 1 | 0.02 | pioglitazone hcl particle size |
873 | 1 | 0.02 | phytochemical screening of medicinal pla... |
874 | 1 | 0.02 | plumeria rubra wound healing |
875 | 1 | 0.02 | swayam prakash srivastava |
876 | 1 | 0.02 | literature review of nanotechnology in d... |
877 | 1 | 0.02 | hydroxy etyhyl cellulose gel formulation... |
878 | 1 | 0.02 | evaluation of microsphere |
879 | 1 | 0.02 | kap of mothers on diarrheal disease and ... |
880 | 1 | 0.02 | microsponges drug delivery system pdf |
881 | 1 | 0.02 | oral disintegrating tablets |
882 | 1 | 0.02 | anti convulsant activity of medicinal pl... |
883 | 1 | 0.02 | drug delivery system environmental impac... |
884 | 1 | 0.02 | review on types of tablets delivery syst... |
885 | 1 | 0.02 | validation cuantification metronidazole |
886 | 1 | 0.02 | how activities of drug are checked on ca... |
887 | 1 | 0.02 | journal of mucoadhesive buccal patch |
888 | 1 | 0.02 | drug delivery systems history pdf |
889 | 1 | 0.02 | history of drug delivery systems |
890 | 1 | 0.02 | c3 c4 complement sle |
891 | 1 | 0.02 | adiantum+review+applications+pdf |
892 | 1 | 0.02 | current status on ethanobotany |
893 | 1 | 0.02 | dose of phenytoin 25 mg/kg in rats antic... |
894 | 1 | 0.02 | orally disintegrating tablets benefits |
895 | 1 | 0.02 | metformin on urea creatinine level in ra... |
896 | 1 | 0.02 | overview of orodispersible tablets |
897 | 1 | 0.02 | project management in delivering nano te... |
898 | 1 | 0.02 | praneet opanasopit |
899 | 1 | 0.02 | http://www.tjpr.org/vol11_no5/2012_11_5_... |
900 | 1 | 0.02 | klancke, j. 2003. dissolution testing of... |
901 | 1 | 0.02 | pdf journal international extraction of ... |
902 | 1 | 0.02 | phytochemical screening of plants |
903 | 1 | 0.02 | antipyretic :pdf |
904 | 1 | 0.02 | wafer pharmaceutical product technolo |
905 | 1 | 0.02 | extraction myristic acids from nutmegs.p... |
906 | 1 | 0.02 | application of nanotechnology in drug de... |
907 | 1 | 0.02 | factors that lead to the waiting time in... |
908 | 1 | 0.02 | formulation & evaluation of carvedilol n... |
909 | 1 | 0.02 | sublingual tablets of glibenclamide |
910 | 1 | 0.02 | psychiatric patients counseling pharmacy... |
911 | 1 | 0.02 | orally disintegrating tablets products t... |
912 | 1 | 0.02 | how to develop discriminatory dissolutio... |
913 | 1 | 0.02 | brown d. orally disintegrating tablets- |
914 | 1 | 0.02 | http://www.tjpr.org/vol11_no4/2012_11_4_... |
915 | 1 | 0.02 | researches in pharmaceutical methods |
916 | 1 | 0.02 | research articles on floating microspher... |
917 | 1 | 0.02 | new innovative latest nanotechnology pro... |
918 | 1 | 0.02 | pdf suppositories release journal nigeri... |
919 | 1 | 0.02 | analgesic effect of salam leaves.pdf |
920 | 1 | 0.02 | uses of seed oils, hibiscus in the cosme... |
921 | 1 | 0.02 | application of nanomaterial in drug deli... |
922 | 1 | 0.02 | articles on diabetes related to knowledg... |
923 | 1 | 0.02 | carica papayaleaf extract effecton gluco... |
924 | 1 | 0.02 | diclofenac biopharmaceutics classificati... |
925 | 1 | 0.02 | why do we formulate orodispersible table... |
926 | 1 | 0.02 | troical journal of pharmacetuical resera... |
927 | 1 | 0.02 | orodispersible tablets friability |
928 | 1 | 0.02 | glucose 6-phosphatase extraction |
929 | 1 | 0.02 | high c3 level |
930 | 1 | 0.02 | tropical journal of phatmaceutical resea... |
931 | 1 | 0.02 | stability indicating method by hplc on ... |
932 | 1 | 0.02 | % recovery of extraction from plasma |
933 | 1 | 0.02 | compliance of sublingual versus oral tab... |
934 | 1 | 0.02 | bktrus33 |
935 | 1 | 0.02 | solvent used in pharmacy |
936 | 1 | 0.02 | tropical journal of pharmaceutical rese... |
937 | 1 | 0.02 | orodispersible tablets review pdf |
938 | 1 | 0.02 | orange g spectrophotometry |
939 | 1 | 0.02 | scisearch nutraceuticals |
940 | 1 | 0.02 | different drugs using floating bioadhesi... |
941 | 1 | 0.02 | bioequivalence between capsule and table... |
942 | 1 | 0.02 | how many alstonia's can i plant in 3 km ... |
943 | 1 | 0.02 | metod of drug delivery,pdf, review,drug ... |
944 | 1 | 0.02 | how quickly does a tablet need to disint... |
945 | 1 | 0.02 | ergosta,5,25-diene,diol |
946 | 1 | 0.02 | chloroquine spectrophotometry |
947 | 1 | 0.02 | dapi staining for apoptosis pdf |
948 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
949 | 1 | 0.02 | tramadol hcl sustained release pellets |
950 | 1 | 0.02 | "orally disintegrating tablets: a review... |
951 | 1 | 0.02 | pharmacological activity plumeria alba p... |
952 | 1 | 0.02 | metoprolol succinate mucoadhesive patch |
953 | 1 | 0.02 | metronidazole extraction methanol |
954 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
955 | 1 | 0.02 | the use of nanotechnology in pharmacy an... |
956 | 1 | 0.02 | "linearity * calibration curve was linea... |
957 | 1 | 0.02 | pumpkin seed oil dark spots skin -book |
958 | 1 | 0.02 | metronidazole free pdf assay by hplc |
959 | 1 | 0.02 | three solvent ratio |
960 | 1 | 0.02 | faculty of pharmacy,niger delta universi... |
961 | 1 | 0.02 | ganesh chaulang, ashok bhosale, piyush p... |
962 | 1 | 0.02 | carbopol based diclofenac sodium gel |
963 | 1 | 0.02 | amino acid, antioxidant and ion profiles... |
964 | 1 | 0.02 | antacid odt tablet |
965 | 1 | 0.02 | prevalence of hcv and hiv infection amon... |
966 | 1 | 0.02 | other names of orally disintegrating tab... |
967 | 1 | 0.02 | the prevalence of hypertension in nigeri... |
968 | 1 | 0.02 | discover genes of nigella sativa |
969 | 1 | 0.02 | background of nanotechnology |
970 | 1 | 0.02 | a study to assess the knowledge on diabe... |
971 | 1 | 0.02 | active phamaceutical ingredients ionic l... |
972 | 1 | 0.02 | questionnaire to assess knowledge of dia... |
973 | 1 | 0.02 | what is super ii transport release mecha... |
974 | 1 | 0.02 | pharmaceutical journals tha donot charge... |
975 | 1 | 0.02 | importance of ethnobotany |
976 | 1 | 0.02 | eudragit rspo as tablet binder |
977 | 1 | 0.02 | antimalarial prescribing and dispensing ... |
978 | 1 | 0.02 | unripe pawpaw and diabetic rats |
979 | 1 | 0.02 | sublingual tablets review pdf |
980 | 1 | 0.02 | orally disintegrating tablets attributes |
981 | 1 | 0.02 | repackaging and stability of solid oral ... |
982 | 1 | 0.02 | journals - diabetic patients knowledge |
983 | 1 | 0.02 | development and evaluation of floating p... |
984 | 1 | 0.02 | enhancer alcohol glycol |
985 | 1 | 0.02 | knowledge, attitude and practices on man... |
986 | 1 | 0.02 | metronidazole hplc acetonitrile phosphat... |
987 | 1 | 0.02 | microsphere formulation.pdf |
988 | 1 | 0.02 | methylene blue confirmatory test for lac... |
989 | 1 | 0.02 | modified chitosan magnetic particle file... |
990 | 1 | 0.02 | disintegration time of buccal tablet |
991 | 1 | 0.02 | current plastic bpa controversies |
992 | 1 | 0.02 | disintegration of tablets definition |
993 | 1 | 0.02 | "in vitro" "μg/ml" "mic" "minimum inhib... |
994 | 1 | 0.02 | articles on self emulsifying drug delive... |
995 | 1 | 0.02 | a review article on oral drug tablets |
996 | 1 | 0.02 | cinnamomum zeylanicum use in diabetes tr... |
997 | 1 | 0.02 | odt tabl;ets |
998 | 1 | 0.02 | nanotechnology drug delivery.pdf |
999 | 1 | 0.02 | factor ethnobotany, age |
1000 | 1 | 0.02 | levels of native c3 in serum |
1001 | 1 | 0.02 | bio analytical method development of met... |
1002 | 1 | 0.02 | diabetic and knowledge deficit. |
1003 | 1 | 0.02 | high-density oral drug delivery systems ... |
1004 | 1 | 0.02 | floating microspheres,entrapment efficie... |
1005 | 1 | 0.02 | best penetration enhancers for skin care |
1006 | 1 | 0.02 | petroleum ether for hair |
1007 | 1 | 0.02 | instrument disintegration for orally des... |
1008 | 1 | 0.02 | ethnobotany significance pdf |
1009 | 1 | 0.02 | detremination of nevirapine |
1010 | 1 | 0.02 | zhongming.qian@yahoo.com |
1011 | 1 | 0.02 | osmotic pump tablet.pdf |
1012 | 1 | 0.02 | oro-dispersible tablets pdf |
1013 | 1 | 0.02 | validation pharmaceutical report |
1014 | 1 | 0.02 | orodispersible tablets an overview |
1015 | 1 | 0.02 | orally disintegrating tablet |
1016 | 1 | 0.02 | rajmeet singh |
1017 | 1 | 0.02 | reaction mechanism for the synthesis of ... |
1018 | 1 | 0.02 | what are the virtus of nanotechonology ... |
1019 | 1 | 0.02 | piper crocatum ruiz & pav and cancer.pdf |
1020 | 1 | 0.02 | nanotechnology and its application in ph... |
1021 | 1 | 0.02 | phytochemical screening |
1022 | 1 | 0.02 | historical aspect of nanotechnology ,rev... |
1023 | 1 | 0.02 | mass spectral data of 19-hydroxy pentacy... |
1024 | 1 | 0.02 | reactivators used in organophosphate poi... |
1025 | 1 | 0.02 | oral disintegration tablets |
1026 | 1 | 0.02 | pharmacognostic analysis in plant artic... |
1027 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1028 | 1 | 0.02 | chloranilic valsartan |
1029 | 1 | 0.02 | disintegration of tablets in stomach |
1030 | 1 | 0.02 | whÄch layer of skÄn is impor... |
1031 | 1 | 0.02 | nanotoxicology - interactions of nanomat... |
1032 | 1 | 0.02 | literature review of nanotechnology |
1033 | 1 | 0.02 | orally dissolving tablet vaccine |
1034 | 1 | 0.02 | jurnal drug tradisional herba piper croc... |
1035 | 1 | 0.02 | how tablet disintegrate into stomoch |
1036 | 1 | 0.02 | low c4 levels |
1037 | 1 | 0.02 | lupus and low c3 c4 |
1038 | 1 | 0.02 | african journal of pharmacy and pharmaco... |
1039 | 1 | 0.02 | why antacids are preffered in odt tablet |
1040 | 1 | 0.02 | validation quantification metronidazole ... |
1041 | 1 | 0.02 | chitosan salts antioxidant |
1042 | 1 | 0.02 | phytochemical screening tests of alkalo... |
1043 | 1 | 0.02 | solution stability in hplc |
1044 | 1 | 0.02 | level of diabetic pain in malaysian |
1045 | 1 | 0.02 | serum urea in albino rats. |
1046 | 1 | 0.02 | antibiotics susceptibility pattern of e ... |
1047 | 1 | 0.02 | which theophylline pill is coated |
1048 | 1 | 0.02 | bioequivalence, pharmacokinetic for meto... |
1049 | 1 | 0.02 | international journals medicinal herbal ... |
1050 | 1 | 0.02 | glycyrrhiza glabra l. research papers 20... |
1051 | 1 | 0.02 | fast dissolving gels |
1052 | 1 | 0.02 | fl spectrophtometric determinatio of ome... |
1053 | 1 | 0.02 | biopharmaceutical classification list fi... |
1054 | 1 | 0.02 | antiprotozoal activity |
1055 | 1 | 0.02 | boerhaavia diffusa extract |
1056 | 1 | 0.02 | education level and knowledge of diabete... |
1057 | 1 | 0.02 | applications of nanotechnology in drug d... |
1058 | 1 | 0.02 | which of the following would you expect ... |
1059 | 1 | 0.02 | l30d water lag time |
1060 | 1 | 0.02 | chemical constituents and biological pro... |
1061 | 1 | 0.02 | carissa carandas linn |
1062 | 1 | 0.02 | doughari jh. 2006. antimicrobial activit... |
1063 | 1 | 0.02 | celecoxib dissolution |
1064 | 1 | 0.02 | tropical rainforest as the source for li... |
1065 | 1 | 0.02 | self-medication with antibiotics ,in nig... |
1066 | 1 | 0.02 | spectrophotometer method "uv vis" filety... |
1067 | 1 | 0.02 | oral bioavailabilty enhancement of poorl... |
1068 | 1 | 0.02 | permeation enhancers in transdermal drug... |
1069 | 1 | 0.02 | pk oral vs tablet formulations reviews |
1070 | 1 | 0.02 | faculte de science de togo |
1071 | 1 | 0.02 | e coli and ciprofloxacin pdf |
1072 | 1 | 0.02 | antiepileptic activity of medicinal plan... |
1073 | 1 | 0.02 | knowledge about complications of diabete... |
1074 | 1 | 0.02 | odt journals |
1075 | 1 | 0.02 | nanotechnology background |
1076 | 1 | 0.02 | journal for free effectiveness of plant ... |
1077 | 1 | 0.02 | journal of ethnobotany with high impact ... |
1078 | 1 | 0.02 | drug delivery using nanotechnology |
1079 | 1 | 0.02 | applications nanotechnology drug deliver... |
1080 | 1 | 0.02 | disintegration of odts |
1081 | 1 | 0.02 | how to observe the particle shape in mic... |
1082 | 1 | 0.02 | importance of ethnobotant pdf |
1083 | 1 | 0.02 | transmucosal drug delivery systems |
1084 | 1 | 0.02 | pharmaceutical research |
1085 | 1 | 0.02 | preparation methods of microspheres file... |
1086 | 1 | 0.02 | what is rapidly disintegrating |
1087 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1088 | 1 | 0.02 | nanotechnology in drug delivery |
1089 | 1 | 0.02 | 83 c3 complement serum 11 c4 somplement ... |
1090 | 1 | 0.02 | download formulation of tablet |
1091 | 1 | 0.02 | dill seed anethum graveolens l "hens" fi... |
1092 | 1 | 0.02 | coating ratio |
1093 | 1 | 0.02 | vidyasur@rediffmail.com |
1094 | 1 | 0.02 | tropical journal of pharmacological rese... |
1095 | 1 | 0.02 | can u tk tablet wit without water |
1096 | 1 | 0.02 | orodispersible tablets pdf |
1097 | 1 | 0.02 | method validation of tramadolhcl by u.v |
1098 | 1 | 0.02 | research on gloriosa superba |
1099 | 1 | 0.02 | rapidly dissolving tablets literatures |
1100 | 1 | 0.02 | schizonepeta |
1101 | 1 | 0.02 | stavudine microspheres pdf |
1102 | 1 | 0.02 | research study on diabetes mellitus - kn... |
1103 | 1 | 0.02 | patrick and nanotechnology drug delivery |
1104 | 1 | 0.02 | purified water validation filetype:pdf |
1105 | 1 | 0.02 | how drug applied in nanotechnological l... |
1106 | 1 | 0.02 | effects of ligustilide on tumor growth a... |
1107 | 1 | 0.02 | journals for pharma and indigenous knowl... |
1108 | 1 | 0.02 | non-pharmacopoeial test for odt |
1109 | 1 | 0.02 | what are tablet still choice of formulat... |
1110 | 1 | 0.02 | anticonvulsant activity of |
1111 | 1 | 0.02 | it generally follows the disintegration ... |
1112 | 1 | 0.02 | how many pages would 6000 words double s... |
1113 | 1 | 0.02 | journal deptt of pharmaceutical sciences... |
1114 | 1 | 0.02 | journals about diuretic activity |
1115 | 1 | 0.02 | advantage of odt drug |
1116 | 1 | 0.02 | www.tjpr.org+2009_8_3_10_bandarkar |
1117 | 1 | 0.02 | 2?p=2 |
1118 | 1 | 0.02 | new dosage form exclusivity in europe |
1119 | 1 | 0.02 | n acetyl cystien in sle |
1120 | 1 | 0.02 | saponins as anticonvulsant |
1121 | 1 | 0.02 | top down approach nanotechnology gecko |
1122 | 1 | 0.02 | difference between hpmc 6 cps & hpmc e5 |
1123 | 1 | 0.02 | desjeux, p., 2004. leishmaniasis: curren... |
1124 | 1 | 0.02 | bionanotechnology pdf |
1125 | 1 | 0.02 | metal analysis by nitric perchloric acid... |
1126 | 1 | 0.02 | filetype:pdf preventive therapy site:org |
1127 | 1 | 0.02 | difference between orodispersible tablet... |
1128 | 1 | 0.02 | disadvantages of newly developed dosage ... |
1129 | 1 | 0.02 | research papers on pyrazole pdf |
1130 | 1 | 0.02 | orally disintegrating tablets and class ... |
1131 | 1 | 0.02 | orally disintegrating tablets formulatio... |
1132 | 1 | 0.02 | review papers in nanotechnology drug del... |
1133 | 1 | 0.02 | "disintegrate+rapidly,+usually+in+a+matt... |
1134 | 1 | 0.02 | "patients' knowledge of diabetes mellitu... |
1135 | 1 | 0.02 | orodispersible tablets of |
1136 | 1 | 0.02 | gelatin gel enterapment efficiency |
1137 | 1 | 0.02 | global issue on addiction |
1138 | 1 | 0.02 | drug delivery systems using nanotechnolo... |
1139 | 1 | 0.02 | quantity of hpmc 5cps for coating |
1140 | 1 | 0.02 | pending manuscript |
1141 | 1 | 0.02 | the study of solid dispersion |
1142 | 1 | 0.02 | what is an oral disintegrating tablet |
1143 | 1 | 0.02 | gastric floating 2011 |
1144 | 1 | 0.02 | compound formulations transdermal |
1145 | 1 | 0.02 | dsc and x-rd studies |
1146 | 1 | 0.02 | review article on chewable tablets |
1147 | 1 | 0.02 | recent trends in nanotechnology in medic... |
1148 | 1 | 0.02 | pharmaceutical coating solution viscosit... |
1149 | 1 | 0.02 | plasticity of enteric polymers |
1150 | 1 | 0.02 | seyed alireza mortazavi |
1151 | 1 | 0.02 | chemists in the rest of the world (by e... |
1152 | 1 | 0.02 | anticonvulsant activity screening |
1153 | 1 | 0.02 | sustained released formulation |
1154 | 1 | 0.02 | taste masked odt of poor solubility and ... |
1155 | 1 | 0.02 | research related to knowledge of diabete... |
1156 | 1 | 0.02 | pharmacokinetics of drugs dissolved on t... |
1157 | 1 | 0.02 | revised pharmaceutical nano technology |
1158 | 1 | 0.02 | root growth observation protocol |
1159 | 1 | 0.02 | formulation and composition of hypromell... |
1160 | 1 | 0.02 | antibiotic activity of sida acuta |
1161 | 1 | 0.02 | complete c4,serum high |
1162 | 1 | 0.02 | glyceryl palmitostearate quantitation me... |
1163 | 1 | 0.02 | methazolamide bioequivalence |
1164 | 1 | 0.02 | journals dealing with current trends in ... |
1165 | 1 | 0.02 | freeze-dried aloe vera gel can dissolve ... |
1166 | 1 | 0.02 | hepatoprotective study |
1167 | 1 | 0.02 | determination dna binding study of antic... |
1168 | 1 | 0.02 | complement c3 c4 elevation differential ... |
1169 | 1 | 0.02 | creatinine clearance after drug administ... |
1170 | 1 | 0.02 | elevated c4 level with normal c3 level |
1171 | 1 | 0.02 | filetype:pdf oil dispersion therapy site... |
1172 | 1 | 0.02 | stability indicating hplc method for |
1173 | 1 | 0.02 | serum compliments concentrations |
1174 | 1 | 0.02 | review on osmotic pump tablets.pdf |
1175 | 1 | 0.02 | utete district hospital |
1176 | 1 | 0.02 | tropic phamarcy journal of research' |
1177 | 1 | 0.02 | www.kattankulathur sex srm college |
1178 | 1 | 0.02 | new dosage forms market exclusivity ex... |
1179 | 1 | 0.02 | articles for controlled release tablets |
1180 | 1 | 0.02 | anti-pyretic activity |
1181 | 1 | 0.02 | what's a disintegrating tablet |
1182 | 1 | 0.02 | "cardot" + "ivivc" filetype:pdf |
1183 | 1 | 0.02 | review on pharmaceutical tablet |
1184 | 1 | 0.02 | oral dosage form tablets advantages |
1185 | 1 | 0.02 | robustness in dissolution validation |
1186 | 1 | 0.02 | vitamin d3 odt tablet |
1187 | 1 | 0.02 | elevated c4 antigen |
1188 | 1 | 0.02 | avicel density |
1189 | 1 | 0.02 | ascorbic acid odt tablets |
1190 | 1 | 0.02 | average pharmacy wait time |
1191 | 1 | 0.02 | list of free international pharmaceutica... |
1192 | 1 | 0.02 | method used for the preparation of float... |
1193 | 1 | 0.02 | open acess journal collection |
1194 | 1 | 0.02 | login to tjpr |
1195 | 1 | 0.02 | ketoacidosis t lymphocyte |
1196 | 1 | 0.02 | formulation emulsion for turmeric |
1197 | 1 | 0.02 | books on orally disintegrating tablets |
1198 | 1 | 0.02 | beta carotene hplc method |
1199 | 1 | 0.02 | challenges of malaria vaccine developmen... |
1200 | 1 | 0.02 | formulation and evaluation of matrix tab... |
1201 | 1 | 0.02 | research articles on hydrogels filetype:... |
1202 | 1 | 0.02 | pradeep r vavia |
1203 | 1 | 0.02 | orally disintegrating tablets and first ... |
1204 | 1 | 0.02 | pdf journal of amaranthus tricolor |
1205 | 1 | 0.02 | @rediffmail.com el urea |
1206 | 1 | 0.02 | the compression force utilized is less t... |
1207 | 1 | 0.02 | rachel nimenibo uadia |
1208 | 1 | 0.02 | oral disintegrating tablet, pharmacokine... |
1209 | 1 | 0.02 | pharmaceutical research format |
1210 | 1 | 0.02 | first oral disintegrating tablet |
1211 | 1 | 0.02 | nano drug delivery systems/plant virus/p... |
1212 | 1 | 0.02 | size of plga nanoparticles decreases as ... |
1213 | 1 | 0.02 | roles and responsibilities of clinical p... |
1214 | 1 | 0.02 | nanotechnology in drug discovery pdf |
1215 | 1 | 0.02 | recent work on nano technology in pharma... |
1216 | 1 | 0.02 | triterpenes in combretaceae filetype:p... |
1217 | 1 | 0.02 | which of the following is a category 3 p... |
1218 | 1 | 0.02 | filetype:pdf potentiometric analysis of ... |
1219 | 1 | 0.02 | cv for bioequivalence study of metronida... |
1220 | 1 | 0.02 | what is a orally disintegrating tablet |
1221 | 1 | 0.02 | structure activity relationship of ampho... |
1222 | 1 | 0.02 | calibration curve of metrinidazole by hp... |
1223 | 1 | 0.02 | kap of mothers on dirrheal disease |
1224 | 1 | 0.02 | journal of pharmaceutical research (2011... |
1225 | 1 | 0.02 | invivo bioavailability study on fast dis... |
1226 | 1 | 0.02 | misconception and knowledge correlation ... |
1227 | 1 | 0.02 | koay yen chin |
1228 | 1 | 0.02 | moleculer weight of chitosan |
1229 | 1 | 0.02 | nanotechnology approaches to bipass firs... |
1230 | 1 | 0.02 | nanoparticles – a review vj mohanraj1*... |
1231 | 1 | 0.02 | metronidazole lc-ms |
1232 | 1 | 0.02 | how many pages is 590 words double space... |
1233 | 1 | 0.02 | metformin low potassium |
1234 | 1 | 0.02 | gcms analysis of rubiaceae |
1235 | 1 | 0.02 | high dose odt tablets |
1236 | 1 | 0.02 | vijay g somani |
1237 | 1 | 0.02 | rationale for tablet vs capsule dosage f... |
1238 | 1 | 0.02 | benin city water supply |
1239 | 1 | 0.02 | average molecular weight of avicel 101 |
1240 | 1 | 0.02 | dextromethorphan lozenge bioequivalence |
1241 | 1 | 0.02 | drug delivery system nanotechnology |
1242 | 1 | 0.02 | at http://www.tjpr.org |
1243 | 1 | 0.02 | virus nanotechnologypdf |
1244 | 1 | 0.02 | premature infants disadvantages oral dos... |
1245 | 1 | 0.02 | researcharticle oral disintigratimg tabe... |
1246 | 1 | 0.02 | gentalek 80 mg |
1247 | 1 | 0.02 | des jeux p leishmaniasis current situati... |
1248 | 1 | 0.02 | c3 c4 hgh diseases |
1249 | 1 | 0.02 | geriatric dysphagia management with liqu... |
1250 | 1 | 0.02 | load cell dka 25t/5100 |
1251 | 1 | 0.02 | can mesoprostol be used as standard drug... |
1252 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1253 | 1 | 0.02 | utkal university + amulya ratna behara |
1254 | 1 | 0.02 | oral disintegrating tablet why peel |
1255 | 1 | 0.02 | references reviewed.odt |
1256 | 1 | 0.02 | simulated gastric fluid ph 6.8 |
1257 | 1 | 0.02 | formulation of fast-release gastroretent... |
1258 | 1 | 0.02 | +234 university of nigeria@yahoo.com |
1259 | 1 | 0.02 | lupus c3 and c4 |
1260 | 1 | 0.02 | g. petroianu pharmacology pdf |
1261 | 1 | 0.02 | manoi, f., 2007, sirih merah sebagai tan... |
1262 | 1 | 0.02 | metronid error codes |
1263 | 1 | 0.02 | low complement c# level and crest |
1264 | 1 | 0.02 | journal the function of mouthwash in den... |
1265 | 1 | 0.02 | http://www.tjpr.org/vol11_no5/2012_11_5_... |
1266 | 1 | 0.02 | indigofera tinctoria |
1267 | 1 | 0.02 | b.c.behera and s.dhal |
1268 | 1 | 0.02 | when are chemical enhancers used in tran... |
1269 | 1 | 0.02 | glibenclamide nanoparticles |
1270 | 1 | 0.02 | genetic transformation is a powerful too... |
1271 | 1 | 0.02 | orally disintegrating tablets exclusivit... |
1272 | 1 | 0.02 | non-aquoeus titrimetric assay of drugs i... |
1273 | 1 | 0.02 | review article on pellet drug delivery s... |
1274 | 1 | 0.02 | sublingual tablets european pharmacopoei... |
1275 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1276 | 1 | 0.02 | validation of pharmaceutical process equ... |
1277 | 1 | 0.02 | sodium chloride toothpaste |
1278 | 1 | 0.02 | review artical on orodispersible tablets |
1279 | 1 | 0.02 | compliance tables versus chewable tablet... |
1280 | 1 | 0.02 | skin permeation enhancers |
1281 | 1 | 0.02 | patients’ assessment of pharmacists’... |
1282 | 1 | 0.02 | production of heptaene antifungal antibi... |
1283 | 1 | 0.02 | freshly isolated essential oils were kep... |
1284 | 1 | 0.02 | formulation and evaluation of ointment f... |
1285 | 1 | 0.02 | nanotechnology drug delivery systems |
1286 | 1 | 0.02 | knowledge on diabetes mellitus in the se... |
1287 | 1 | 0.02 | oral disintegrating tablet for psychiat... |
1288 | 1 | 0.02 | what is the meaning of crs in misoprosto... |
1289 | 1 | 0.02 | 14. srinivas s.a., dandagi p.m. and gada... |
1290 | 1 | 0.02 | bahi calixte |
1291 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1292 | 1 | 0.02 | properties of metronidazole |
1293 | 1 | 0.02 | indomethacin as a standard drug in tpa i... |
1294 | 1 | 0.02 | ketoacidosis in male/female |
1295 | 1 | 0.02 | filetype:pdf powder processing apparatus... |
1296 | 1 | 0.02 | excipients used for molded sublingual ta... |
1297 | 1 | 0.02 | filetype:pdf functional film coating of... |
1298 | 1 | 0.02 | pdf of osmotic tablet |
1299 | 1 | 0.02 | what is orally disintegrating tablet |
1300 | 1 | 0.02 | antiproliferative activity of plant extr... |
1301 | 1 | 0.02 | example of review papers on nanotechnolo... |
1302 | 1 | 0.02 | odt freeze drying pdf |
1303 | 1 | 0.02 | pradeep.r. vavia |
1304 | 1 | 0.02 | tropical journl |
1305 | 1 | 0.02 | transdermal gel hydrophobic |
1306 | 1 | 0.02 | important indices in journal ethno botan... |
1307 | 1 | 0.02 | jurnal gastroretentive with swelling age... |
1308 | 1 | 0.02 | stability indicting method for hplc |
1309 | 1 | 0.02 | cotton candy process odt |
1310 | 1 | 0.02 | using preservatives in topical creams |
1311 | 1 | 0.02 | when to begin change control drug develo... |
1312 | 1 | 0.02 | effect of molecular weight plasticizer p... |
1313 | 1 | 0.02 | filetype:doc comments writing for report... |
1314 | 1 | 0.02 | pdf gc ms tocopherols in olive oil |
1315 | 1 | 0.02 | orally disintegrating tablets bioequival... |
1316 | 1 | 0.02 | nutmeg properties, journal works |
1317 | 1 | 0.02 | oral form+contact angle |
1318 | 1 | 0.02 | free fraction of drugs bioequivalence |
1319 | 1 | 0.02 | lymphocyte higher in diabetes mellitus k... |
1320 | 1 | 0.02 | nanotechnology & drug delivery |
1321 | 1 | 0.02 | an assessment of the level of knowledge ... |
1322 | 1 | 0.02 | absorbed more rapidly: a drug dissolved ... |
1323 | 1 | 0.02 | tropical j phar res |
1324 | 1 | 0.02 | stability indicating assay of domperidon... |
1325 | 1 | 0.02 | 2θ value of gelucire |
1326 | 1 | 0.02 | corchorus olitorius tlc method |
1327 | 1 | 0.02 | assay of metformin hydrochloride by hplc |
1328 | 1 | 0.02 | disintegration site of drugs |
1329 | 1 | 0.02 | x ray diffraction of microspheres filety... |
1330 | 1 | 0.02 | plant biotechnology |
1331 | 1 | 0.02 | pharm. tech., 30(10), 28–37 (2006). |
1332 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1333 | 1 | 0.02 | sabinene "minimum inhibitory concentrati... |
1334 | 1 | 0.02 | prof djaman |
1335 | 1 | 0.02 | applied virology and nanotechnology |
1336 | 1 | 0.02 | any journal about ethnobotanical methods... |
1337 | 1 | 0.02 | different orals forms in india pharmacy... |
1338 | 1 | 0.02 | history of drug delivering |
1339 | 1 | 0.02 | taste of meloxicam |
1340 | 1 | 0.02 | studies on medicinal plant treatment of ... |
1341 | 1 | 0.02 | chewable tablet and first pass effect |
1342 | 1 | 0.02 | difference between disperse and disinteg... |
1343 | 1 | 0.02 | effect of papaya leaf extract on glucos... |
1344 | 1 | 0.02 | pradeep r vavia citation index |
1345 | 1 | 0.02 | orodispersible tablets: an overview |
1346 | 1 | 0.02 | physical properties of cefuroxime axetil |
1347 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1348 | 1 | 0.02 | role of oximes in organophosphorus |
1349 | 1 | 0.02 | filetype:doc comments on prospectus site... |
1350 | 1 | 0.02 | complement c4 serum levels high |
1351 | 1 | 0.02 | awareness and knowledge of diabetes |
1352 | 1 | 0.02 | benefits oral disintegrating tablet |
1353 | 1 | 0.02 | review article on various factors affect... |
1354 | 1 | 0.02 | renoprotective effect of extract |
1355 | 1 | 0.02 | nanobiotech approach for drug |
1356 | 1 | 0.02 | microsponge drug delivery system |
1357 | 1 | 0.02 | hpmc solution 300 cps |
1358 | 1 | 0.02 | odt advantages |
1359 | 1 | 0.02 | research article on nerium oleander |
1360 | 1 | 0.02 | odt in indian pharmacopeia |
1361 | 1 | 0.02 | orally dissintegration tablet |
1362 | 1 | 0.02 | dregea volubilis |
1363 | 1 | 0.02 | glycyrrhiza glabra extraction process |
1364 | 1 | 0.02 | isolation and identification of plant (f... |
1365 | 1 | 0.02 | alstonia boonei de wild. |
1366 | 1 | 0.02 | tropical journal of pharmaceutical rese... |
1367 | 1 | 0.02 | burst coating for tablets |
1368 | 1 | 0.02 | bee venom pham duy lam |
1369 | 1 | 0.02 | "purified water" "water for injection" "... |
1370 | 1 | 0.02 | &usg=afqjcneta3azl2s9czqvq_oxhs4hu9c62a |
1371 | 1 | 0.02 | the discovery of nanotechnology as drugs... |
1372 | 1 | 0.02 | tropical journal of pharmaceutical scine... |
1373 | 1 | 0.02 | use of nanotechnology to deviber drugs |
1374 | 1 | 0.02 | metronidazole 250 mg + spiramycin cmax |
1375 | 1 | 0.02 | determine the similarity requirements fo... |
1376 | 1 | 0.02 | gliclazide nanoparticles |
1377 | 1 | 0.02 | antioxidant and antihaemolytic activitie... |
1378 | 1 | 0.02 | analytical method developed for metronid... |
1379 | 1 | 0.02 | black snakes in nigeria |
1380 | 1 | 0.02 | ethnobotany and modern medicine |
1381 | 1 | 0.02 | journals from pakistan pharmacy |
1382 | 1 | 0.02 | disintegration time for odt |
1383 | 1 | 0.02 | hirani orally disintegrating |
1384 | 1 | 0.02 | dicyclomine dsc |
1385 | 1 | 0.02 | diospyros preussi |
1386 | 1 | 0.02 | disintegration time capsule too fast |
1387 | 1 | 0.02 | plasto elasticity of drug excipient |
1388 | 1 | 0.02 | nigerian who have worked with response s... |
1389 | 1 | 0.02 | formulation and evaluation of nanopartic... |
1390 | 1 | 0.02 | film coating surface sem |
1391 | 1 | 0.02 | antimicrobial effect of nigeria medicina... |
1392 | 1 | 0.02 | what is a positive c3 serum? |
1393 | 1 | 0.02 | validation of pharmaceutical water syste... |
1394 | 1 | 0.02 | trop. j. pharm. res. |
1395 | 1 | 0.02 | marine pharmacognosy abstract |
1396 | 1 | 0.02 | osmotic coating systems delayed release |
1397 | 1 | 0.02 | benefits of rainforest in medicine(journ... |
1398 | 1 | 0.02 | abstract uv-visible spectrophotometric m... |
1399 | 1 | 0.02 | - deepak, k. orally disintegrating table... |
1400 | 1 | 0.02 | disintegration of tablets downloaded fre... |
1401 | 1 | 0.02 | essential lipids with antibacterial eff... |
1402 | 1 | 0.02 | gentamycin induced nephrotoxicity revers... |
1403 | 1 | 0.02 | poloxamine eo/po swelling |
1404 | 1 | 0.02 | pharmaceutical tablet packaging strip te... |
1405 | 1 | 0.02 | nanobiotechnology drug delivery |
1406 | 1 | 0.02 | hard gelatin capsules disintegration tim... |
1407 | 1 | 0.02 | malla reddy college of pharmacy maisamma... |
1408 | 1 | 0.02 | metronidazole in human plasma by hplc |
1409 | 1 | 0.02 | rapid disintegrating tablet |
1410 | 1 | 0.02 | why does herbal medicine have a difficul... |
1411 | 1 | 0.02 | appolinary kamuhabwa tz |
1412 | 1 | 0.02 | diuretic effect of liophylised aquieus a... |
1413 | 1 | 0.02 | adhirajan n, ravi kumar t, shanmugasunda... |
1414 | 1 | 0.02 | . prakash. k, raju p. n, shanta k.k and... |
1415 | 1 | 0.02 | tropical journal of pharmaceutical r... |
1416 | 1 | 0.02 | tropican journal of pharmacy reserachy |
1417 | 1 | 0.02 | refractive index 0.1m h2so4 |
1418 | 1 | 0.02 | properties of oral films pdf |
1419 | 1 | 0.02 | review on blister packaging of tablets f... |
1420 | 1 | 0.02 | concentration range of eudragit l 100 in... |
1421 | 1 | 0.02 | cinnamomum zeylanicum |
1422 | 1 | 0.02 | c4 serum |
1423 | 1 | 0.02 | free radic boil method |
1424 | 1 | 0.02 | gao s, zhao y, gou p, chen n, xie y. pre... |
1425 | 1 | 0.02 | hplc grewia pdf |
1426 | 1 | 0.02 | formets for validation in pharma |
1427 | 1 | 0.02 | drug delivery pdf |
1428 | 1 | 0.02 | eudragit permeability rxs |
1429 | 1 | 0.02 | balanites aegyptiaca |
1430 | 1 | 0.02 | pleurotus tuber regium |
1431 | 1 | 0.02 | orallly disintegrating |
1432 | 1 | 0.02 | orodispersible tablets |
1433 | 1 | 0.02 | selection of solvent system in film coat... |
1434 | 1 | 0.02 | studies on addiction and wealthy |
1435 | 1 | 0.02 | tropical journal in pharmaceutical resea... |
1436 | 1 | 0.02 | how does an orally disintegrating tablet... |
1437 | 1 | 0.02 | can an orally disintegrating tablet be c... |
1438 | 1 | 0.02 | banaras hindu university+melt extrusion |
1439 | 1 | 0.02 | sustained release matrix tablets of dilt... |
1440 | 1 | 0.02 | review article tropic infection 2012 pdf |
1441 | 1 | 0.02 | role of clinical pharmacist in saudi ara... |
1442 | 1 | 0.02 | what is gast res tablets for |
1443 | 1 | 0.02 | protein precipitation plasma estimation |
1444 | 1 | 0.02 | pdf of new drug registration of enzy mes... |
1445 | 1 | 0.02 | http://www.tjpr.org/vol8_no3/2009_8_3_11... |
1446 | 1 | 0.02 | chitosan alginate factorial design filet... |
1447 | 1 | 0.02 | buspirone fda bioequivalence |
1448 | 1 | 0.02 | journal of pharmaceutical manufacturing ... |
1449 | 1 | 0.02 | process validation protocol |
1450 | 1 | 0.02 | oral delivery drug otd |
1451 | 1 | 0.02 | orally dissintegrated tablets |
1452 | 1 | 0.02 | hydroxypropyl methylcellulose in film co... |
1453 | 1 | 0.02 | introduction & background of nanotechnol... |
1454 | 1 | 0.02 | total cholesterol aqueous extract |
1455 | 1 | 0.02 | knowledge attitudes practices behavior g... |
1456 | 1 | 0.02 | can orally disintegrating tablets be cal... |
1457 | 1 | 0.02 | bilayer tablets pdf |
1458 | 1 | 0.02 | coating film hydroxypropylmethylcellulos... |
1459 | 1 | 0.02 | gelatin microsphere oral |
1460 | 1 | 0.02 | herbal sunscreen lotion + formulation fi... |
1461 | 1 | 0.02 | review artical on tablet ib capsule pdf |
1462 | 1 | 0.02 | antihypertensive compound in tropical ra... |
1463 | 1 | 0.02 | challenges and vaccine development to ma... |
1464 | 1 | 0.02 | bioavailability dietary supplements,odt |
1465 | 1 | 0.02 | cu nanoparticles sulfonylurea preparatio... |
1466 | 1 | 0.02 | extraction de anethum graveolens pdf |
1467 | 1 | 0.02 | antiproliferative ,nasopharyngeal cancer... |
1468 | 1 | 0.02 | osmotic pump tablet |
1469 | 1 | 0.02 | kap of mothers on diarrheal disease and... |
1470 | 1 | 0.02 | 3- indolebutyric acid hplc |
1471 | 1 | 0.02 | "formulated to be resistant to gastric a... |
1472 | 1 | 0.02 | strenght of phloroglucinol tablets |
1473 | 1 | 0.02 | hydroxypropyl methylcellulose medical jo... |
1474 | 1 | 0.02 | case studies on effect of drying and mil... |
1475 | 1 | 0.02 | low c3 and c4 levels |
1476 | 1 | 0.02 | melt granulation method for drug formula... |
1477 | 1 | 0.02 | the formulation of solid dosage forms a... |
1478 | 1 | 0.02 | product enhancement technologies in phar... |
1479 | 1 | 0.02 | nanotechnology and drug delivery pdf |
1480 | 1 | 0.02 | gcms analysisof fattyacid in croton spar... |
1481 | 1 | 0.02 | delivery of biological products nanotech... |
1482 | 1 | 0.02 | dots limitation in nigeria |
1483 | 1 | 0.02 | how improve the stability of the tablet ... |
1484 | 1 | 0.02 | hplc method of oryza sativa |
1485 | 1 | 0.02 | antimicrobial activity exhibiting plants |
1486 | 1 | 0.02 | advantages of tropical route of oral adm... |
1487 | 1 | 0.02 | "glycyrrhiza glabra" filetype:pdf |
1488 | 1 | 0.02 | adiantum+review+pdf |
1489 | 1 | 0.02 | bacillus subtilis atcc 6633 mic penicili... |
1490 | 1 | 0.02 | interpreting c3 and c4 results with lupu... |
1491 | 1 | 0.02 | edmund kayombo 2012 |
1492 | 1 | 0.02 | drug delivery and nanobiotechnology + pd... |
1493 | 1 | 0.02 | curcumin nanoparticles for hepatoprotect... |
1494 | 1 | 0.02 | differential scanning calorimeter school... |
1495 | 1 | 0.02 | tropicaljournal of pharmaceutical resear... |
1496 | 1 | 0.02 | tropical journal 0f pharm research |
1497 | 1 | 0.02 | glycyrrhiza glabra (mulethi) clinical da... |
1498 | 1 | 0.02 | irrational prescribing of antimalarials |
1499 | 1 | 0.02 | temperature increase during extrusion us... |
1500 | 1 | 0.02 | toothpaste efficacy in the reduction of ... |
1501 | 1 | 0.02 | patients’ acceptability oral medicine... |
1502 | 1 | 0.02 | nano drug delivery journals nature |
1503 | 1 | 0.02 | nanotechnology and drug |
1504 | 1 | 0.02 | gloriosa superba- research article |
1505 | 1 | 0.02 | effect of ampicillin on staphylococcus a... |
1506 | 1 | 0.02 | how to design water system for pharmaceu... |
1507 | 1 | 0.02 | monograph of odt tablets |
1508 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1509 | 1 | 0.02 | review related to knowledge,attitude and... |
1510 | 1 | 0.02 | phytoconstituents of myanmar medicinal p... |
1511 | 1 | 0.02 | powder characteristics of saraca asoca |
1512 | 1 | 0.02 | african journal of pharmaceutical scienc... |
1513 | 1 | 0.02 | aripiprazole,oral disintegrant |
1514 | 1 | 0.02 | bioavailability and disintegration |
1515 | 1 | 0.02 | j. mass spectrom-2-pentanone, 4-hydroxy-... |
1516 | 1 | 0.02 | hypolipidemic screening filetype:pdf |
1517 | 1 | 0.02 | food nanotechnology in nigeria |
1518 | 1 | 0.02 | 234 ajibola@yahoo.com |
1519 | 1 | 0.02 | lithium induced benin |
1520 | 1 | 0.02 | penetration enhancement methods |
1521 | 1 | 0.02 | nano technology as specila drug deliver... |
1522 | 1 | 0.02 | spectrophotometric estimation of ceftria... |
1523 | 1 | 0.02 | synthesis of isoniazid derivatives |
1524 | 1 | 0.02 | syed wasif gilliani warfarin |
1525 | 1 | 0.02 | is there any difference between chronoth... |
1526 | 1 | 0.02 | manuscript changed status to review (s)... |
1527 | 1 | 0.02 | hplc method for metronidazole for human ... |
1528 | 1 | 0.02 | eudragit rl po in pulsatile drug deliver... |
1529 | 1 | 0.02 | ethylcellulose floating microspheres by ... |
1530 | 1 | 0.02 | drug release from film-coated tablet |
1531 | 1 | 0.02 | blood glucose level estimation in athero... |
1532 | 1 | 0.02 | dill seed anethum graveolens.l chicks f... |
1533 | 1 | 0.02 | filetype:pdf process for its preparation... |
1534 | 1 | 0.02 | extended release matrix tablet 2011artic... |
1535 | 1 | 0.02 | glyceryl monostearate carboxylic |
1536 | 1 | 0.02 | floating oral filetype:pdf |
1537 | 1 | 0.02 | floating microspheres 2012 |
1538 | 1 | 0.02 | do orally disintegrating tablets undergo... |
1539 | 1 | 0.02 | biological and pharmaceutical nanomateri... |
1540 | 1 | 0.02 | chang r, guo x, burnside ba and couch ra... |
1541 | 1 | 0.02 | research article on orodispersible table... |
1542 | 1 | 0.02 | nanotechnology related to drug delivary |
1543 | 1 | 0.02 | sustained release pdf |
1544 | 1 | 0.02 | s.venkataraman + clbaid metha |
1545 | 1 | 0.02 | ifeanyi yahoo.coo +234 |
1546 | 1 | 0.02 | analysis of hplc lod loq |
1547 | 1 | 0.02 | chitosan ibuprofen transdermal |
1548 | 1 | 0.02 | chemical constituents and biological pro... |
1549 | 1 | 0.02 | carvedilol tablet formulation |
1550 | 1 | 0.02 | propylene glycol as enhancer of ibuprofe... |
1551 | 1 | 0.02 | stability indicating method by hplc on d... |
1552 | 1 | 0.02 | in oleic acid and dmso which is best per... |
1553 | 1 | 0.02 | difference between formulation tablet |
1554 | 1 | 0.02 | peak purity determination |
1555 | 1 | 0.02 | new extraction techniques of cynara scol... |
1556 | 1 | 0.02 | physiocochemical properties of amodiaqui... |
1557 | 1 | 0.02 | importance ethnobotanical investigation ... |
1558 | 1 | 0.02 | fomulation by solid dispersion technique |
1559 | 1 | 0.02 | guar gum miscibility pullulan |
1560 | 1 | 0.02 | water ratio after dryer coatings |
1561 | 1 | 0.02 | trop j pharm res, june 2012;11(3): 363 |
1562 | 1 | 0.02 | dissolution vs disintegration for odt |
1563 | 1 | 0.02 | evaluation using pole climbing apparatus... |
1564 | 1 | 0.02 | orally disentegrating tablet |
1565 | 1 | 0.02 | nanoparticles based odt in marketed |
1566 | 1 | 0.02 | patient medication counselling survey |
1567 | 1 | 0.02 | press coating of tablet.pdf |
1568 | 1 | 0.02 | pharmacological research 2012 65 (4): 43... |
1569 | 1 | 0.02 | evaluation of odt tablets |
1570 | 1 | 0.02 | osmotic tablet pdf |
1571 | 1 | 0.02 | starch dosage by spectrometric methods f... |
1572 | 1 | 0.02 | stability indicating method by hplc on d... |
1573 | 1 | 0.02 | sublingual tablet a review pdf |
1574 | 1 | 0.02 | (glycyrrhiza hair |
1575 | 1 | 0.02 | tropical journal of pharmaceutical rese... |
1576 | 1 | 0.02 | emanual vamanu |
1577 | 1 | 0.02 | dosage forms containing taste masked act... |
1578 | 1 | 0.02 | ethylene propylene oxide limonene |
1579 | 1 | 0.02 | history of nanotechnology |
1580 | 1 | 0.02 | down load free articles of compressional... |
1581 | 1 | 0.02 | bioequivalence between conventional and ... |
1582 | 1 | 0.02 | swelling ratio eudragit rs rl |
1583 | 1 | 0.02 | reserpineextraction p-rocess |
1584 | 1 | 0.02 | antioxidant and wound healing properties... |
1585 | 1 | 0.02 | antistress activity of anethum graveole... |
1586 | 1 | 0.02 | mjor antioxidant in cynara scolymus |
1587 | 1 | 0.02 | limit of water content in lozenge dosage... |
1588 | 1 | 0.02 | flora r. aigbe |
1589 | 1 | 0.02 | difference between osmotic coating and n... |
1590 | 1 | 0.02 | hair growth promoting herbs |
1591 | 1 | 0.02 | multiparticulate system in dissolution |
1592 | 1 | 0.02 | orally disintegrating tablets: a review. |
1593 | 1 | 0.02 | protease purification carbohydrate conte... |
1594 | 1 | 0.02 | +234 nigeria ... |
1595 | 1 | 0.02 | related:cipzmhwe6e8j:scholar.google.com/ |
1596 | 1 | 0.02 | tablet formulation pdf |
1597 | 1 | 0.02 | if the download does not start automatic... |
1598 | 1 | 0.02 | dregea volubilis benth cultivation |
1599 | 1 | 0.02 | phthalates and diabetes pdf |
1600 | 1 | 0.02 | amino acid anti oxidant and ionic profil... |
1601 | 1 | 0.02 | conventionally compressed tablets |
1602 | 1 | 0.02 | induction of oxidative stress in albino ... |
1603 | 1 | 0.02 | hemidesmus indicus review |
1604 | 1 | 0.02 | patient wait time analysis |
1605 | 1 | 0.02 | effect of herbal extract a nd rt pcr in ... |
1606 | 1 | 0.02 | cpcsea guidelines 2012 |
1607 | 1 | 0.02 | x-ray diffraction analysis for drug-poly... |
1608 | 1 | 0.02 | trop. j. pharm res. |
1609 | 1 | 0.02 | asparaginase production procedures |
1610 | 1 | 0.02 | nigerian journal of pharmaceutical resea... |
1611 | 1 | 0.02 | morinda morindoides |
1612 | 1 | 0.02 | nanotechnology in drug delivery download... |
1613 | 1 | 0.02 | tjpr impact factor |
1614 | 1 | 0.02 | review articals on orodispersible tablet... |
1615 | 1 | 0.02 | reducing power on chitosan pdf |
1616 | 1 | 0.02 | meloxicam orodispersible |
1617 | 1 | 0.02 | nanotechnology drug synthesis compounds |
1618 | 1 | 0.02 | http://www.tjpr.org/vol4_no1/41itioloa.h... |
1619 | 1 | 0.02 | chemical penetration enhancers |
1620 | 1 | 0.02 | knowledge deficit in diabetes |
1621 | 1 | 0.02 | literature review of ibuprofen orally ... |
1622 | 1 | 0.02 | c4 levels in patients with lupus nephrit... |
1623 | 1 | 0.02 | c4 complement elevated |
1624 | 1 | 0.02 | lyophilized tablets |
1625 | 1 | 0.02 | melt granulation process for sustain rel... |
1626 | 1 | 0.02 | pharmaceutical nanotechnology applicatio... |
1627 | 1 | 0.02 | literature review on mother's knowledge ... |
1628 | 1 | 0.02 | c3 in sle |
1629 | 1 | 0.02 | extended spectrum beta lactamase e. coli... |
1630 | 1 | 0.02 | what is the effect of heat on oral-disin... |
1631 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1632 | 1 | 0.02 | 'bkdas72@yahoo.com' |
1633 | 1 | 0.02 | c3 and c4 levels |
1634 | 1 | 0.02 | odekupacking and cohesive properties of ... |
1635 | 1 | 0.02 | eudragit rl & rs matrix tablets |
1636 | 1 | 0.02 | ethnomedical uses of trema guineensis |
1637 | 1 | 0.02 | questionnaire to assess knowledge of dia... |
1638 | 1 | 0.02 | pdf in all about transdermal drug delive... |
1639 | 1 | 0.02 | tjpr.org |
1640 | 1 | 0.02 | tropical journal of pharmacetical resear... |
1641 | 1 | 0.02 | dicyclomine gastoretentive research arti... |
1642 | 1 | 0.02 | chemical e-maÄl: * * " " @rediffma... |
1643 | 1 | 0.02 | 2. explain the various techniques used i... |
1644 | 1 | 0.02 | stevia pharmaceutical review |
1645 | 1 | 0.02 | phase diagram of poly(ethylene oxide)-po... |
1646 | 1 | 0.02 | venomous snakes in nigeria |
1647 | 1 | 0.02 | nanomaterials applications in drug deliv... |
1648 | 1 | 0.02 | hirani, j., rathod, d., vadalia, k.; ora... |
1649 | 1 | 0.02 | fenugreek ointment vehicle |
1650 | 1 | 0.02 | hair growth promotant activity of petrol... |
1651 | 1 | 0.02 | standard ratio of drug, polymer and solv... |
1652 | 1 | 0.02 | niger delta university school of pharmac... |
1653 | 1 | 0.02 | benefits of oral dissolve tablets |
1654 | 1 | 0.02 | rajaonarivelo jacob |
1655 | 1 | 0.02 | selection of coating solvents for tablet... |
1656 | 1 | 0.02 | drug selection criteria for orodispersib... |
1657 | 1 | 0.02 | odt formulation |
1658 | 1 | 0.02 | penetration enhancers |
1659 | 1 | 0.02 | alkaloids ulcer |
1660 | 1 | 0.02 | freeze drying methods manufacturing ora... |
1661 | 1 | 0.02 | curcumin hepg2 12-well cell viability |
1662 | 1 | 0.02 | new drug delivery systems-nantechology |
1663 | 1 | 0.02 | hpmc burst effect with alcohol |
1664 | 1 | 0.02 | diclofenac dispersion solid journal |
1665 | 1 | 0.02 | complement c3 serum high |
1666 | 1 | 0.02 | crushing strenght of yam |
1667 | 1 | 0.02 | effect of antioxidants on ftir spectrum |
1668 | 1 | 0.02 | tropical journal of pharnaceutical scien... |
1669 | 1 | 0.02 | simethicone odt formulation |
1670 | 1 | 0.02 | possible drug candidates of freeze dry p... |
1671 | 1 | 0.02 | uv led tn58 |
1672 | 1 | 0.02 | 32.zhou z, chu b: light scattering stud... |
1673 | 1 | 0.02 | subhakanta kanungo |
1674 | 1 | 0.02 | odt pharma |
1675 | 1 | 0.02 | dissolution of artemether tablets |
1676 | 1 | 0.02 | hugbo |
1677 | 1 | 0.02 | tahir mehmoud khan and king faisal |
1678 | 1 | 0.02 | procedure to check disintegration time o... |
1679 | 1 | 0.02 | pharmaceutical journals |
1680 | 1 | 0.02 | introduction of orodispersible tablet.pd... |
1681 | 1 | 0.02 | piper crocatum experimental study rat |
1682 | 1 | 0.02 | nanoparticle drug delivery background |
1683 | 1 | 0.02 | formulation and evaluation of gastrorete... |
1684 | 1 | 0.02 | drugs that can be formulated as oral dis... |
1685 | 1 | 0.02 | c3 serum |
1686 | 1 | 0.02 | carvedilol phosphate articles |
1687 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1688 | 1 | 0.02 | tea breast milk .pdf |
1689 | 1 | 0.02 | new analytical method for the determinat... |
1690 | 1 | 0.02 | alumina used in drug delivery |
1691 | 1 | 0.02 | ufr biosciences, université de cocody-a... |
1692 | 1 | 0.02 | anticonvulsant journal pdf |
1693 | 1 | 0.02 | biotechnology bee filetype:pdf |
1694 | 1 | 0.02 | study of the solvent in the oven of coat... |
1695 | 1 | 0.02 | film thin strip pharmaceutical |
1696 | 1 | 0.02 | drug delivery nanotechnology |
1697 | 1 | 0.02 | medical plant botany filetype:pdf |
1698 | 1 | 0.02 | diffraction band od polypropyleneoxide |
1699 | 1 | 0.02 | fast dissolving tablet of nevirapine |
1700 | 1 | 0.02 | down load free pdf's ofeffect of compre... |
1701 | 1 | 0.02 | viscosity of hpmc e5 |
1702 | 1 | 0.02 | basavaraj nanjwade editor |
1703 | 1 | 0.02 | bridelia ferruginea+pills |
1704 | 1 | 0.02 | nature nanobiotehnology drug presentatio... |
1705 | 1 | 0.02 | nano drug delivery book |
1706 | 1 | 0.02 | journal of tropical pharmacy |
1707 | 1 | 0.02 | lethality properties and antioxidants pr... |
1708 | 1 | 0.02 | discriminative dissolution method for su... |
1709 | 1 | 0.02 | disintegration and tablet matrix strengt... |
1710 | 1 | 0.02 | standard curve preparation of metronidaz... |
1711 | 1 | 0.02 | onah & ajima |
1712 | 1 | 0.02 | antibiotic testing of urine isolates |
1713 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1714 | 1 | 0.02 | bisphenol levels in water in india |
1715 | 1 | 0.02 | carvedilol matrix tablet articles |
1716 | 1 | 0.02 | nigella sativa clinical trial pdf |
1717 | 1 | 0.02 | newbouldia laevis uses |
1718 | 1 | 0.02 | knowledge and practice of mother regardi... |
1719 | 1 | 0.02 | erim gülcan |
1720 | 1 | 0.02 | kalanchoe sante |
1721 | 1 | 0.02 | chemical composition and antibacterial a... |
1722 | 1 | 0.02 | bornylene ri hp-5ms |
1723 | 1 | 0.02 | 2000 knowledge regarding diarrhea among... |
1724 | 1 | 0.02 | decoction preparation pdf |
1725 | 1 | 0.02 | diabetic wound healing by plant oil file... |
1726 | 1 | 0.02 | difference between buccal tablets and fa... |
1727 | 1 | 0.02 | hcv coninfection with other tti markers ... |
1728 | 1 | 0.02 | dmso permeation enhancer |
1729 | 1 | 0.02 | formulation of orodispersible tablets |
1730 | 1 | 0.02 | when pharmaceutical powders are compress... |
1731 | 1 | 0.02 | reddy, l.h., et al.2002, kuchekar b.s., ... |
1732 | 1 | 0.02 | where to get minxidil cream in benin nig... |
1733 | 1 | 0.02 | purpose of orodispersable |
1734 | 1 | 0.02 | nano drug delivery system |
1735 | 1 | 0.02 | odt pharmaceutical |
1736 | 1 | 0.02 | simvastatin orodispersible tablet pdf |
1737 | 1 | 0.02 | quick dissolving wafers |
1738 | 1 | 0.02 | aceclofenac extended release tablets 200... |
1739 | 1 | 0.02 | time difference between intake of 2 diff... |
1740 | 1 | 0.02 | tdz |
1741 | 1 | 0.02 | review of litrature in virus pharma feel... |
1742 | 1 | 0.02 | oral medication wafer systems review |
1743 | 1 | 0.02 | oral flash tablets |
1744 | 1 | 0.02 | orally disintegrating tablets: a review... |
1745 | 1 | 0.02 | evaluation of cellulose in direct compre... |
1746 | 1 | 0.02 | determination of metronidazole |
1747 | 1 | 0.02 | critical process parameters for coating ... |
1748 | 1 | 0.02 | determination of lod and loq in hplc |
1749 | 1 | 0.02 | nutritional importance of bridelia ferru... |
1750 | 1 | 0.02 | metronidazole with hplc method water an... |
1751 | 1 | 0.02 | k v ramana murty pdf |
1752 | 1 | 0.02 | mechanism of chitosan-hobt |
1753 | 1 | 0.02 | electronic drug delivery systems history |
1754 | 1 | 0.02 | plant extract in di ethyl ether |
1755 | 1 | 0.02 | orally disintegrating tablet review |
1756 | 1 | 0.02 | usp labs analyzer 2 dissolver |
1757 | 1 | 0.02 | advantages of oral tablets |
1758 | 1 | 0.02 | doe for fast disinntegrating tablets |
1759 | 1 | 0.02 | faisal muti alhassan |
1760 | 1 | 0.02 | anticancer activity of plant extracts br... |
1761 | 1 | 0.02 | viruses_and_nanotechnology.pdf |
1762 | 1 | 0.02 | bilayer tablet of microparticles |
1763 | 1 | 0.02 | antioxidant role of medicinal plants fil... |
1764 | 1 | 0.02 | a review on recent advancement in the de... |
1765 | 1 | 0.02 | solvent mixture evaporation rate |
1766 | 1 | 0.02 | sawsan a omer king saud university |
1767 | 1 | 0.02 | toxic heavy metals by naveed |
1768 | 1 | 0.02 | lyophilized sublingual tablets excipient... |
1769 | 1 | 0.02 | method for extraction cellulose from cot... |
1770 | 1 | 0.02 | herbal drugs suitable for floating micro... |
1771 | 1 | 0.02 | disintegration time of orally disintegra... |
1772 | 1 | 0.02 | nanotechnology drug delivery courses onl... |
1773 | 1 | 0.02 | journal orally disintegrating tablet |
1774 | 1 | 0.02 | spiramycin metronidazole in human plasma |
1775 | 1 | 0.02 | composition of the essential oil of clau... |
1776 | 1 | 0.02 | avicel ph101 filetype:pdf |
1777 | 1 | 0.02 | orodispersible tablets review article |
1778 | 1 | 0.02 | assessment of diabetic patients knowledg... |
1779 | 1 | 0.02 | government arts college chidambaram chem... |
1780 | 1 | 0.02 | extraction and invivo antiplasmodium act... |
1781 | 1 | 0.02 | 4 |
1782 | 1 | 0.02 | solid oral dosage formulation review |
1783 | 1 | 0.02 | drug delivery by nano |
1784 | 1 | 0.02 | formulation of sustained release matrix ... |
1785 | 1 | 0.02 | burst pressure tablet coating eudragit r... |
1786 | 1 | 0.02 | controlled release matrix tablets of ace... |
1787 | 1 | 0.02 | tropicacal journal |
1788 | 1 | 0.02 | stability-indicating hplc method |
1789 | 1 | 0.02 | tests for determination of metronidazole |
1790 | 1 | 0.02 | oraly desintegrating tablets benefits |
1791 | 1 | 0.02 | orally disintegrating tablet patient edu... |
1792 | 1 | 0.02 | pharmacological research on asteraceae |
1793 | 1 | 0.02 | paracetamol mouth dissolving tablets ing... |
1794 | 1 | 0.02 | publication fee 400 us |
1795 | 1 | 0.02 | review article on pellet dosage form fil... |
1796 | 1 | 0.02 | calendula officinalis filetype:pdf |
1797 | 1 | 0.02 | anticonvulsant activity of plant extract... |
1798 | 1 | 0.02 | +234 nigeria ... |
1799 | 1 | 0.02 | tropical j of pharmaceutical research im... |
1800 | 1 | 0.02 | stability study of aceclofenac sodium ta... |
1801 | 1 | 0.02 | tropical marine actinomycetes, review |
1802 | 1 | 0.02 | http://www.tjpr.org/vol8_no2/2009_8_2_10... |
1803 | 1 | 0.02 | hpmc k4m molecular weight |
1804 | 1 | 0.02 | formulation and optimization of celecoxi... |
1805 | 1 | 0.02 | glycyrrhiza glabra for hair |
1806 | 1 | 0.02 | pdf nanotechnology book |
1807 | 1 | 0.02 | microcrystalline cellulose extraction so... |
1808 | 1 | 0.02 | relation between nanotechnology and drug... |
1809 | 1 | 0.02 | review of literature on tablets (introdi... |
1810 | 1 | 0.02 | metformin hcl hplc and uv methods |
1811 | 1 | 0.02 | effect of naoh on antibiotic test pdf |
1812 | 1 | 0.02 | donepezil odt bioequivalence |
1813 | 1 | 0.02 | filetype:pdf cgmp ultrapure water standa... |
1814 | 1 | 0.02 | journal research gastroretentive swellin... |
1815 | 1 | 0.02 | presentation about caesalpiniaceae |
1816 | 1 | 0.02 | orally disintigrating tablets |
1817 | 1 | 0.02 | pharma coting mechnisam pdf |
1818 | 1 | 0.02 | stability indicating hplc method for tra... |
1819 | 1 | 0.02 | tropican journal ogf pharmacy reserach |
1820 | 1 | 0.02 | s. madan, g .n. singh, k. kohli, m. ali,... |
1821 | 1 | 0.02 | routes drugs penetrate skin via transder... |
1822 | 1 | 0.02 | poloxamer in topical drug delivery syste... |
1823 | 1 | 0.02 | serum complement levels |
1824 | 1 | 0.02 | matrix tablets for oral controlled relea... |
1825 | 1 | 0.02 | mepressor tablets by novartis |
1826 | 1 | 0.02 | nanotechnology in novel drug delivery sy... |
1827 | 1 | 0.02 | a simple uv spectrophotometric method fo... |
1828 | 1 | 0.02 | drug entrapment efficiency method for p... |
1829 | 1 | 0.02 | radioactive ethanolamine |
1830 | 1 | 0.02 | presentation formate on research methodo... |
1831 | 1 | 0.02 | syed wasif gillani |
1832 | 1 | 0.02 | http://www.tjpr.org/instructions.php |
1833 | 1 | 0.02 | glass found in furosemide |
1834 | 1 | 0.02 | kumaran fibrinolytic enzyme |
1835 | 1 | 0.02 | ionic effervescents in formulation of od... |
1836 | 1 | 0.02 | local drug delivery system of antiinflam... |
1837 | 1 | 0.02 | manasamitra vatakam |
1838 | 1 | 0.02 | odt drug candidates properties |
1839 | 1 | 0.02 | characertstics of orally disintegratong ... |
1840 | 1 | 0.02 | literatuer reivew on kap of mother on di... |
1841 | 1 | 0.02 | reactions of chloroacetyl chloride with ... |
1842 | 1 | 0.02 | m foirs hra ak, mishra a, chattopadhyay ... |
1843 | 1 | 0.02 | 5fu in dmso solution raman spectrum |
1844 | 1 | 0.02 | bridelia ferruginea pdf |
1845 | 1 | 0.02 | tropical journal of phermaceuticals impa... |
1846 | 1 | 0.02 | plant extract preparation, wound healing |
1847 | 1 | 0.02 | orally disintegrating tablets; a review-... |
1848 | 1 | 0.02 | tropicasn journal of pharmacy reserach |
1849 | 1 | 0.02 | lecithin filetype:pdf |
1850 | 1 | 0.02 | training pharmacist to deal psych patien... |
1851 | 1 | 0.02 | school of medicine,atbu bauchi |
1852 | 1 | 0.02 | pharmacological activities of plants pdf |
1853 | 1 | 0.02 | osmotic agent ratio in osmotic pump |
1854 | 1 | 0.02 | dmso penetration enhancer |
1855 | 1 | 0.02 | assessing patients' purchase of medicati... |
1856 | 1 | 0.02 | ic50 t47d breast cancer cells |
1857 | 1 | 0.02 | how to get free of cost hard copy of ph... |
1858 | 1 | 0.02 | lupus sle analysis complement c4 serum |
1859 | 1 | 0.02 | benefits of nano drug delivery |
1860 | 1 | 0.02 | arun sethi, lucknow university |
1861 | 1 | 0.02 | assay of capsules |
1862 | 1 | 0.02 | “ orally disintegrating tablets: a rev... |
1863 | 1 | 0.02 | pdf for buccal tablet of anti psychotic |
1864 | 1 | 0.02 | emphasis on diagnosis on nanotechnology ... |
1865 | 1 | 0.02 | artificial intelligence in formulation d... |
1866 | 1 | 0.02 | how perform stability indicating method? |
1867 | 1 | 0.02 | girijananda institute of pharmaceutical ... |
1868 | 1 | 0.02 | metformin in floating system |
1869 | 1 | 0.02 | nanostructured silicon in drug delivery |
1870 | 1 | 0.02 | garg r, and gupta gd, “progress in con... |
1871 | 1 | 0.02 | eudragit |
1872 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1873 | 1 | 0.02 | stability testing of aceclofenac tablets... |
1874 | 1 | 0.02 | tadalafil orally disperse tablet |
1875 | 1 | 0.02 | anotechnology and drugs delivery |
1876 | 1 | 0.02 | pleurotus tuber regium journal |
1877 | 1 | 0.02 | orally disintegrating tablet absorption |
1878 | 1 | 0.02 | orodispersible, tablet |
1879 | 1 | 0.02 | trop j pharm res |
1880 | 1 | 0.02 | troican jouranl of pharmacy reserach |
1881 | 1 | 0.02 | a detail about tablet manufacturing pdf |
1882 | 1 | 0.02 | how to compute wait time hospital study |
1883 | 1 | 0.02 | european patent specification tadalafil ... |
1884 | 1 | 0.02 | domperidone proniosomes |
1885 | 1 | 0.02 | drugs undergo first path effect on the m... |
1886 | 1 | 0.02 | a review of poloxamer 407 pharmaceutical... |
1887 | 1 | 0.02 | bisphenol a |
1888 | 1 | 0.02 | metronidazole plasma recovery method |
1889 | 1 | 0.02 | filetype:pdf college of medicine univers... |
1890 | 1 | 0.02 | review articles on fast dissolving table... |
1891 | 1 | 0.02 | total ash value and bitterness value |
1892 | 1 | 0.02 | theophyllin clarke's f value |
1893 | 1 | 0.02 | antiproliferative activity of plant extr... |
1894 | 1 | 0.02 | quantitative determination of reserpine |
1895 | 1 | 0.02 | local name of clausena suffruticosa |
1896 | 1 | 0.02 | osmotic d drug study pdf |
1897 | 1 | 0.02 | odt first pass metabolism |
1898 | 1 | 0.02 | odt disintegration time |
1899 | 1 | 0.02 | elaeagnus conferta fruit |
1900 | 1 | 0.02 | green chemistry and sustainable developm... |
1901 | 1 | 0.02 | reserch artical of oral disintegrating t... |
1902 | 1 | 0.02 | role of health care professional in phar... |
1903 | 1 | 0.02 | sr matrix tablet of diltiazem hydrochlor... |
1904 | 1 | 0.02 | properties of saraca indica in points |
1905 | 1 | 0.02 | promy virk |
1906 | 1 | 0.02 | organoleptic properties of plants |
1907 | 1 | 0.02 | nanostructured drugs in market |
1908 | 1 | 0.02 | limonia acidissima fruit pdf |
1909 | 1 | 0.02 | nanotech in drug delivery |
1910 | 1 | 0.02 | disintegration test of odt as per europe... |
1911 | 1 | 0.02 | synthesis of chalcones in 2011 |
1912 | 1 | 0.02 | drug delivery nano technology papers |
1913 | 1 | 0.02 | is dmf a better solvent than acetone |
1914 | 1 | 0.02 | kuchekar bs, bhise sb, arumugan v design... |
1915 | 1 | 0.02 | elsevier granulator filetype:pdf |
1916 | 1 | 0.02 | p. r. vavia citation index |
1917 | 1 | 0.02 | healthcare professionals awareness in th... |
1918 | 1 | 0.02 | properties fast dissolving tablets pdf |
1919 | 1 | 0.02 | will consumer comply with lozenges more ... |
1920 | 1 | 0.02 | http;//www.tjpr.org |
1921 | 1 | 0.02 | glycyrrhiza hair uses |
1922 | 1 | 0.02 | formulation and evaluation of sustained ... |
1923 | 1 | 0.02 | pharmaceutical nanotechnology based publ... |
1924 | 1 | 0.02 | invitro evaluation of once daily sustain... |
1925 | 1 | 0.02 | standard oral tablet dimensions |
1926 | 1 | 0.02 | sublingual or orally disintegrating? |
1927 | 1 | 0.02 | antioxidant activity of low molecular we... |
1928 | 1 | 0.02 | thin layer chromatography of steroid hor... |
1929 | 1 | 0.02 | sci. pharm. 54 (1986) 331. |
1930 | 1 | 0.02 | review on fast dissolving tablet filetyp... |
1931 | 1 | 0.02 | sem photos of microsponges |
1932 | 1 | 0.02 | stability indicating method by hplc on s... |
1933 | 1 | 0.02 | mcc tablet formulation |
1934 | 1 | 0.02 | journal of pharmacy research |
1935 | 1 | 0.02 | influence/role/effect of nanotechnology ... |
1936 | 1 | 0.02 | research on knowledge of diabetes mellit... |
1937 | 1 | 0.02 | review article on formulation of nigella... |
1938 | 1 | 0.02 | gloriosa superba research |
1939 | 1 | 0.02 | disease associated with increased c4 lev... |
1940 | 1 | 0.02 | enhance cutaneous drug absorption |
1941 | 1 | 0.02 | bilayer tablet of microparticle |
1942 | 1 | 0.02 | are oxazepam tablets ok to take sublingu... |
1943 | 1 | 0.02 | carvedilol sr tablets |
1944 | 1 | 0.02 | clinical pharmacist role nd responsibili... |
1945 | 1 | 0.02 | a qualitative and quantitative assay to ... |
1946 | 1 | 0.02 | nutritional value of bridelia ferruginea... |
1947 | 1 | 0.02 | bee molecular mechanism |
1948 | 1 | 0.02 | calotropis procera antipyretic |
1949 | 1 | 0.02 | formulation and evaluation of oil entrap... |
1950 | 1 | 0.02 | uv estimation of lornoxicam |
1951 | 1 | 0.02 | palmitostearate formation |
1952 | 1 | 0.02 | phytochemical sreening |
1953 | 1 | 0.02 | rising emergence of clinical pharmacist ... |
1954 | 1 | 0.02 | cinnamomum zeylanicum evidance treat dia... |
1955 | 1 | 0.02 | aceclofenac hplc method filetype:pdf |
1956 | 1 | 0.02 | formulation and evaluation of microspher... |
1957 | 1 | 0.02 | http://www.tjpr.org/vol11_no5/2012_11_5_... |
1958 | 1 | 0.02 | journal of pharmaceutical research. 2011... |
1959 | 1 | 0.02 | high molecular weight polyethylene oxide... |
1960 | 1 | 0.02 | factors affecting diabetes knowledge in ... |
1961 | 1 | 0.02 | ethyl cellulose relaxation and effect on... |
1962 | 1 | 0.02 | dr omorodion of uniben |
1963 | 1 | 0.02 | water as penetration enhancer |
1964 | 1 | 0.02 | availability and expiry of essential med... |
1965 | 1 | 0.02 | drug delivery system use in technology.p... |
1966 | 1 | 0.02 | drug transdermal technology |
1967 | 1 | 0.02 | microbaloon oral drug delivery systems f... |
1968 | 1 | 0.02 | influence of nanotechnology in drug disc... |
1969 | 1 | 0.02 | hplc method devlopment of meloxicame and... |
1970 | 1 | 0.02 | hplc method for metronidazole for plasma |
1971 | 1 | 0.02 | sustained released formulation of aceclo... |
1972 | 1 | 0.02 | phloroglucinol+bioequivalence |
1973 | 1 | 0.02 | trop j pharm res. |
1974 | 1 | 0.02 | "international medical university, malay... |
1975 | 1 | 0.02 | tebekeme okoko |
1976 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
1977 | 1 | 0.02 | journal for free effectiveness of tamari... |
1978 | 1 | 0.02 | solvent pentru cefuroxim |
1979 | 1 | 0.02 | curcumin microspheres |
1980 | 1 | 0.02 | a qualitative and quantitative assay to ... |
1981 | 1 | 0.02 | "coating solvent" |
1982 | 1 | 0.02 | fenugreek extract formulation |
1983 | 1 | 0.02 | high complement c4 |
1984 | 1 | 0.02 | licorice extract and plant growth enhanc... |
1985 | 1 | 0.02 | evren algin yapar |
1986 | 1 | 0.02 | drying of methanol extract after concent... |
1987 | 1 | 0.02 | effervescent odt |
1988 | 1 | 0.02 | decreased c3 and c4 serum complement |
1989 | 1 | 0.02 | design and evaluation of colon specific ... |
1990 | 1 | 0.02 | dissertation of herbal hair tonic |
1991 | 1 | 0.02 | . j. pharm. res |
1992 | 1 | 0.02 | tropical j pharm res |
1993 | 1 | 0.02 | nanobiothecnology delyvery drugs |
1994 | 1 | 0.02 | s. p. dewani immunomodulatory activity... |
1995 | 1 | 0.02 | complement c3 low |
1996 | 1 | 0.02 | eric o. uniben pharmacology dept |
1997 | 1 | 0.02 | inderal sharif makhmal zadeh eye drop |
1998 | 1 | 0.02 | recent review articles on sublingual tab... |
1999 | 1 | 0.02 | paper on nanotechnology in drug discover... |
2000 | 1 | 0.02 | gc-ms analysis of essential oil of some ... |
2001 | 1 | 0.02 | filetype:doc purchase pharmacy online si... |
2002 | 1 | 0.02 | lorazepam is absorbed from buccal cavity |
2003 | 1 | 0.02 | melt granulation of tramadol hcl |
2004 | 1 | 0.02 | tropican journal of pharmacy research |
2005 | 1 | 0.02 | odt in terms of patient compliance |
2006 | 1 | 0.02 | rutaceae, india |
2007 | 1 | 0.02 | advantages of oral disintegrating tablet... |
2008 | 1 | 0.02 | effect of bridelia ferruginea ( euphorbi... |
2009 | 1 | 0.02 | esra küpeli akkol gazi university, facu... |
2010 | 1 | 0.02 | determination of polyphenols in plants f... |
2011 | 1 | 0.02 | abbreviation of research in pharmaceutic... |
2012 | 1 | 0.02 | synergy between phenothiazines and oxaci... |
2013 | 1 | 0.02 | who prepare first oral dissolving tablet |
2014 | 1 | 0.02 | nanotechnology material design and synth... |
2015 | 1 | 0.02 | recent advances in herbal cosmaceuticals... |
2016 | 1 | 0.02 | review articles transdermal drug deliver... |
2017 | 1 | 0.02 | ghulam murtaza, naeem amir pharmacy tjpr... |
2018 | 1 | 0.02 | drug properties for odt |
2019 | 1 | 0.02 | floating microspheres with eudragit s 10... |
2020 | 1 | 0.02 | meloxicam solid dispersion tablets |
2021 | 1 | 0.02 | nanotechnology delivery mechanism |
2022 | 1 | 0.02 | nanotechnology drug |
2023 | 1 | 0.02 | atcc 10239 candida albicans |
2024 | 1 | 0.02 | althaf hussain basha research |
2025 | 1 | 0.02 | 40 |
2026 | 1 | 0.02 | nanotech-based drugs and delivery system... |
2027 | 1 | 0.02 | preparation of nitrendipine |
2028 | 1 | 0.02 | greense method in nanotechnalogy-pdf |
2029 | 1 | 0.02 | ethnobotanical journals of sk |
2030 | 1 | 0.02 | rajeev garg g d gupta asbasjsm cop |
2031 | 1 | 0.02 | antipyretic activities |
2032 | 1 | 0.02 | issoufou amadou guowei le |
2033 | 1 | 0.02 | high load orally disintegrating tablets |
2034 | 1 | 0.02 | microsphere of glycerhiza glabra extract... |
2035 | 1 | 0.02 | orange dissolvable tablets for depressio... |
2036 | 1 | 0.02 | eudragit l 100 polymer and its concentra... |
2037 | 1 | 0.02 | centre de biotechnologie de borj cédria... |
2038 | 1 | 0.02 | journal of carissa carandas pdf |
2039 | 1 | 0.02 | medcal plant+culture pdf |
2040 | 1 | 0.02 | too fast tablet disintegration |
2041 | 1 | 0.02 | centaurea + analgesic |
2042 | 1 | 0.02 | advantages of drugs+synthesis |
2043 | 1 | 0.02 | drug remaining method for invivo study f... |
2044 | 1 | 0.02 | floating microsphere research articles |
2045 | 1 | 0.02 | nanotechnology in drug delivery systems |
2046 | 1 | 0.02 | lqc,mqc,hqc |
2047 | 1 | 0.02 | http://www.internationalpharmaceuticalab... |
2048 | 1 | 0.02 | cinnamon zeylanicum on cholesterol resea... |
2049 | 1 | 0.02 | azetidin-2-one 2a |
2050 | 1 | 0.02 | comparison of theoretical and optimized... |
2051 | 1 | 0.02 | effect of medicinal plants on sucrose in... |
2052 | 1 | 0.02 | nanotechnology review articles pdf |
2053 | 1 | 0.02 | nano size drug delivery |
2054 | 1 | 0.02 | solvent drying time in pharma coating |
2055 | 1 | 0.02 | 19. jaysukh j, dhaval a, kantilal r. ora... |
2056 | 1 | 0.02 | animal activity study on eclipta alba in... |
2057 | 1 | 0.02 | purpose of stability indicating method |
2058 | 1 | 0.02 | what is a stability-indicating hplc meth... |
2059 | 1 | 0.02 | serological prediction of infections in ... |
2060 | 1 | 0.02 | tropical journal of pharmaceutical scien... |
2061 | 1 | 0.02 | " preparation, characterization and anti... |
2062 | 1 | 0.02 | african pharmaceutical journals |
2063 | 1 | 0.02 | effect of solvent based coating on core ... |
2064 | 1 | 0.02 | if odt tablet not absorbed sublingually |
2065 | 1 | 0.02 | alkyd oil lenght and hardness |
2066 | 1 | 0.02 | vibhuti kabra, tjpr |
2067 | 1 | 0.02 | tests bioadhesives surgery filetype:pdf |
2068 | 1 | 0.02 | tropical journal of pharmaceutical resea... |
2069 | 1 | 0.02 | pharm disintegration |
2070 | 1 | 0.02 | review papers on nanotechnology |
2071 | 1 | 0.02 | salbutamol and theophylline simultaneous... |
2072 | 1 | 0.02 | phospholpids in pumpkin seed oil |
2073 | 1 | 0.02 | normal c3 & c4 levels |
2074 | 1 | 0.02 | orodispersible tablet forulation |
2075 | 1 | 0.02 | global problems on addiction |
2076 | 1 | 0.02 | abstract review of literature to asses t... |
2077 | 1 | 0.02 | mechanism poly(ethylene oxide)-poly(prop... |
2078 | 1 | 0.02 | orodispersible tablets review |
2079 | 1 | 0.02 | leaves garden cress-rat- |
2080 | 1 | 0.02 | knowledge 'diarrhea' filetype:pdf |
2081 | 1 | 0.02 | knowledge deficit regarding diabetes ill... |
2082 | 1 | 0.02 | bioadhesive particulate system |
2083 | 1 | 0.02 | effects of solvent coating |
2084 | 1 | 0.02 | hygrophila spinosa |
2085 | 1 | 0.02 | snakes in nigeria.pdf |
2086 | 1 | 0.02 | orally disintegrating tablets disadvanta... |
2087 | 1 | 0.02 | odeku and majekodunmi a. boonei tjpr |
2088 | 1 | 0.02 | weakness intermittent preventive treatme... |
2089 | 1 | 0.02 | anticonvulsants mechanism of action in c... |